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Abstract 
Research Question: Transforming growth factor beta (TGF-P) causes growth 
stimulation and transformation in fibroblasts, but growth inhibition/apoptosis in other cell 
types. Previously, TGF-P has been shown to activate the Smad signalling cascade in all 
cell types. Alternative signalling pathways have been described in response to TGF-p. To 
explain how TGF-P controls growth, we investigated a downstream target of 
phosphatidylinositol 3-kinase (PI3K) called Akt. Akt inactivates glycogen synthase 
kinase 3 beta (GSK-3P) and FOXO. We propose that PI3K signalling is partially 
responsible for the different phenotypic effects ofTGF-P in mesenchymal and epithelial 
cells. 
Methods: Western blotting was used to describe temporal changes (0-3 hours) in 
PDK-1 , Akt, GSK-3P and Cyclin D 1 phosphorylation/protein levels with TGF-P2 
stimulation of normal fibroblast and epithelial cell lines. Additionally, we blocked 
the effects of TGF-~ on Akt/GSK-3~ using PI3K/Akt specific inhibitors and 
TGF-~ receptor kinase dead cell lines. Using the UAS/GAL4 system of ectoptic 
gene expression in Drosophila melanogaster, we overexpressed the activated 
Baboon receptor (Activin/TGF-P type I homologue) in an eye-specific manner, 
using early and late developmental drivers. We also coexpressed GSK-3p, 
PI3K0 N and Akt constructs with activated Baboon. Results were documented 
using Scanning Electron Microscopy (SEM). 
Results: TGF-P stimulation increased PDK-1 , Akt and GSK-3P phosphorylation in 
fibroblasts over time. Conversely, TGF-~ stimulation decreased PDK-1, Akt and GSK-3P 
phosphorylation over time in epithelial cells. The GSK-3~ substrate, Cyclin D 1, exhibited 
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decreasing phosphorylation in fibroblast cells, and decreased protein levels of Cyclin D 1 
in epithelial cells. In fibroblasts, TGF-~ increased Cyclin D 1 complex formation with 
CDK-4 and nuclear localization. Conversely, TGF-~ decreased complex formation in 
epithelial cells. TGF-~ stimulated Cyclin D 1/CDK complex formation was blocked by a 
PI3K inhibitor. Morphological transformation by TGF-beta was attenuated by an Akt 
inhibitor in fibroblasts. In Drosophila studies, overexpression of constitutively active 
Baboon in the eye caused overgrowth and patterning defects that was rescued by 
coexpressing either a PI3K0 N mutation, mutant dFOXO or mutant GSK-3p, while 
overexpression of wild-type Akt or PI3K had a synergistic effect. 
Summary: These results, in both cell culture and Drosophila, point to a novel 
mechanism of TGF-~ signaling through PI3K/Akt. In total, these results define a 
novel pathway for TGF-P regulation of cell cycle through PI3K/Akt in normal 
cells. This signalling pathway also differentiates epithelial and fibroblast cell 
responses to TGF-P stimulation. In conjunction with Smads, this pathway could 
account for the cell type specific growth responses to TGF-p. Potential alterations 
of this pathway may be a mechanism by which some cancers elude the normal 
growth regulatory system imposed by TGF-(:3 . 
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Chapter 1: Introduction 
Chapter 1.1: Introduction to Cellular Growth 
The Transforming Growth Factor Beta (TGF-~) superfamily of peptides is 
comprised of key regulators of growth in both developing and differentiated cells 
(Massague et a/. , 2000). However, the mechanisms by which this family of cytokine 
control cellular growth are not clear, causing growth inhibition in some cell types such as 
epithelial and immune, growth stimulation in others, including fibroblast and a cytostatic 
signal to neurons and other cell types (Massague, 2000). There are two primary 
mechanisms of cellular growth: I) increases in cell size and 2) increases in the rate of cell 
division. Cellular growth is influenced by extracellular signals that influence identity 
pattern, structure and final size of the organ in development. Growth in development is 
controlled by the Wingless/Wnt and TGF-~ [(Bone Morphogenetic Protein 
(BMP)/Decapentaplegic (Dpp )] pathways (Johnston and Gallant, 2002). Collectively, 
these pathways result in the modulation of various genes and their respective proteins to 
control metabolic functions that regulate the rate of growth and the differentiation of a 
given cell to ultimately determine the type and size of an organ during development. 
In this project, the prototypic member of the TGF-~ superfamily, TGF-~ and it 
role in cellular growth signalling pathways was investigated. The best characterized 
signal transduction pathway ofTGF-B. action is the Smad pathway ( hi and Massague, 
2003). All categories of cells appear to activate identical receptors and the same 
downstream intracellular pathway (Smads), in response to a ligand despite TGF-~ 
exerting different effects on the same cell types, at different times in development. There 
are several 'alternative' pathways such as the Ras/MAPK, phosphatidylinositol 3-kinase 
(PI3K)/p21 activated kinase 2 (PAK 2) and the PI3K/Akt pathways, have been described 
(Mulder and Morris, 1992;Mulder, 2000;Shin et al., 200l;Yu eta/., 2002;Wilkes et al. 
2003). These pathways have not been well characterized with respect to TGF-~ 
signalling, and have an unknown function in TGF-~ biology. Of particular interest is the 
PI3K/ Akt pathway, as it has been shown to be involved in both cell cycle and cellular 
growth (Brazil eta/., 2004). I wished to investigate the effects of TGF-~ signalling upon 
the downstream target ofPI3K, Akt and also study two direct targets ofthe protein kinase 
Akt, Foxo and GSK-3~ differences in response both in cell culture and Drosophila 
melanogaster. 
Chapter 1.2 TGF -~ Superfamily 
The TGF-~ super-family of growth factors is found in all metazoans (Mehra and 
Wrana, 2002). They are grouped into 3 families: bone morphogenetic proteins (BMPs), 
Activins and TGF-~s. In addition, there are also several other cytokines that are more 
distantly related such as the Growth and Differentiation factors (GDF), Mullerian 
Inhibitory Substances (MIS) and Glial cell-line Derived Neurotrophic Factors (GDNF). 
The prototype of this superfamily is TGF-~ I , a secreted peptide hormone that binds to a 
specific receptor and was first discovered in conditioned media of tissue culture where it 
confers a "transformed" phenotype on normal rat kidney fibroblasts in soft agar (NRK-
49F) and an increase in the rate of collagen production and cellular growth (Assoian, 
1985;Roberts et al., 1986). These results implicated TGF-~ as an important mediator of 
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tissue repair and transformation, hence the name. From the discovery of this growth 
factor, some 28 others have been identified, all homologous in key structw-al domains 
(Mehra et al., 2002). Most of this superfamily are homodimers and have a cysteine knot 
in the protein structure as common features. They are secreted from many cell types a 
precursor molecules that are latent and are stored in the extracellular matrix (Hyytainen et 
al. , 2004). TGF-13 is targeted to the ECM by latent TGF-13 binding proteins (L TBP) to 
wait for the appropriate signal from the matrix then the ligands are cleaved internally to 
form the functional ligand that can act in an autocrine or paracine fashion. There are four 
L TBPs that seem to be specific for each of the three TGF-13 ligands, and are present in 
different tissues, and have developmental differently spliced isoforms. Overall, L TBP 
may confer specify on highly similar ligands as they are divergent in sequence similarity 
and have unique expression patterns. 
There are many varied functions ofthis superfamily, specific to the stage of 
development and the cell type upon which the ligand acts. For example, TGF-13 causes 
many different cell type specific effects, such as being mitogenic to fibroblasts , growth 
inhibitory to epithelial/endothelial cells, a chemoattractant to macrophages and linked to 
both tumourgenesis and wound repair, neovascularization and differentiation of certain 
cell types (Massague, 1998). The Bone Morphogenetic Protein (BMPs) and Activin 
families have been associated more closely to the development of all metazoans. For 
example, Activins have an endocrine function in mammals and are involved in early 
development. As the name suggests, BMPs were first identified as factors that can induce 
mesodermal tissues (such as muscle) into bone but also function in patterning and 
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morphogenesis of early mesoderm in early development, nelli·ogenesis, induction of the 
neural fate and induce somite formation (Massague, 1998). BMPs also act in the limb 
bud by reducing expansion and formation of the chondrocyte and osteoclast precursors 
(Kishigami et al., 2005). After birth, they are involved in maintenance of bone mass, as 
demonstrated by conditional BMP 2/4 double knockout mice, which display slowed 
skeletal growth and postnatal bone formation . The Type II receptor for BMP2/4, bmprl b 
also displays skeletal abnormalities. Dpp, the Drosophila BMP homolog is involved in 
dorsoventral patterning and specification of cell type in the early embryo. 
Another TGF-~ subfamily member, Activin is also involved with neurobiology. 
Activin family members are produced by neurons and are neuroprotective both in vitro 
and in vivo (Werner and Alzhimer, 2006). Activins are also involved in mesoderm 
formation, somatic growth, cell proliferation, apoptosis, branching morphogenesis 
inflammation and reproduction. Drosophila Activin is involved in neural wiring and 
proliferation, regulates mushroom body remodeling in the developing brain and motor 
neuron guidance in the embryo (Parker et al. , 2006). The Type I Activin Receptor, 
Baboon causes reduced proliferation within the optic lobe and central brain reduction in 
the size of the photoreceptor field (Brummel et al. , 1999, Zhu eta!. , 2008) 
Each of the TGF-~ superfamily groups has unique receptors to carry out their 
diverse functions in the cell. These receptors, and their corresponding intracellular ligand 
are outlined in Table 1. While these receptor combinations are not exclusive, they are 
some of the most commonly found in these TGF-~ subfamilies (Schmierer and Hill, 
2007). 
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Table 1: Overview of the major TGF-B subfamilies 
Adapted from Schmierer and Hill, 2007. Drosophila gene names are highlighted in blue. 
Ligand "Family" Ligands Type IIII Receptors Smads 
TGF-13 TGF-13 1,2,3 TGF-13RIIIALK-5 Smad 213, SMOX 
Activin Activin I3A,B,C,E ActRII, ActRIIb, Punt I Smad 2, 3, SMOX 
dActivin, Dawdle ALK 2, 4, 7, Baboon 
BMP-214 BMP 214, DPP BMPRII, Punt/ Smad 1 ,5,8, MAD 
ALK3,6 TKV 
OP-1 BMP5, 6, 7, 8 BMPRII, Punt/ Smad 1,5, MAD 
ALK 2,6 GBB, SCW 
GDF-5 GDF 5, 6, 7 BMPRII I Smad 1,5,8 MAD 
ALK-6 
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Chapter 1.2.1 Signalling of the TGF -13 receptors 
There are three types ofTGF-~ receptors called the Type I, II and III (TGF- ~Rl , 
II and III, respectively). Type I and II are the main ' signalling' receptors, with the type III 
receptor (B-glycan) being involved in some of the TGF-~ functions such as presenting 
TGF-~2 ligand to the receptor complex and acting as a reservoir of active TGF-~ 
(Massague, 2000). All TGF -~receptors classified to date, with the exception of type III, 
have serine-threonine kinase activity. The TGF- ~RII receptor binds directly to a free 
ligand. It is a glycoprotein capable of autophosphorylation and constitutively active 
kinase activity, with a single extracellular domain and a trans-membrane spanning 
domain. The TGF-PI receptor (ALK 1-5, TGF-PRI being ALK5), has four main domain : 
extracellular ligand binding, transmembrane, a cytoplasmic juxtamembrane region 
containing a serine-glycine repeat region or the "GS" domain, and a C-terminus Ser-Thr 
kinase domain. The GS domain is a particularly interesting feature of this protein, being 
highly conserved among ALK receptors and trans phosphorylation of the region by TGF-
~RII results in activation of the TGF-~RI kinase. 
Together, TGF-~RI and RII form the functional signalling complex, as outlined in 
Figure 1. Ligand binds to the previously dimerized TGF-~II receptor (Henis et al., 
1994). Bound ligand/TGF-~RII recruits the 2 TGF-~1 receptors into the complex, 
allowing the TGF-PII receptor to phosphorylate the TGF-PI receptors. Mutation of the 
GS domain (threonine 204 to aspartate) causes a constitutively active form of the TGF-~1 
receptor in the absence of ligand binding. This creates a charged amino acid substitution 
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Unoccupied Receptor 
Recycled 
Eri<-2 !Erk·1l 
Activation 
·ran,sloc:;ati<on' ~ 
Phosphorylation 
------------ - - -- - -- -
lReceptor Internalization 
Nucleus 
Figure 1: Overview of known TGF-~ Signalling Pathway 
TGF -13 receptors are endocytosed into the cell after ligand binding. This leads to the Type 
2 receptor phosphorylation of the Type I receptor, resultant in kinase activity. Type I 
receptors can then phosphorylate R-Smads 2/3, which are brought to the receptor by 
Smad anchor for receptor activation (SARA). Smad 2/3 then binds with the co-Smad4 to 
undergo nuclear translocation, which ultimately leads to gene transcription or repression. 
exist as a dimer), within the GS domain region (Wrana eta/. , 1994). 
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that confers constitutive activity in the absence of ligand (Wieser and Massague, 
1995).These amino acid substitution does not seem to be a site that is phosphorylated in 
Type I receptor activation, but instead lies just outside the site. This 'constitutive activity' 
is also independent of Type II Receptor binding, and is not conserved amongst all TGF-~ 
like receptors, suggesting this may be unique to the TGF-~RI receptor. This activated 
receptor seems to have greater activity than wild-type Type I receptors, which indicates 
that it may not directly mimic natural activation ofTGF-~ signaling. Once the TGF-~1 
receptor is 'activated' it phosphorylates receptor Smads (R-Smads) at specific serine 
residues (Nakao et al. , 1997). The activation of the signaling complex is still an open 
question, with some evidence being presented that receptor endocytosis being needed for 
complete activation. This is thought to occur by bringing all the TGF-~ signaling 
components together in the same compartment. The FYVE domain protein SARA 
promotes uptake of the SARA/Smad complex to endosomal membranes promoting 
clathrin-dependent endocytosis and receptor-mediated activation of Smad proteins 
(Caestecker et al., 2004). There are also sorting nexins which interact with Type I 
receptors and help traffic them across the plasma membrane. A protein called Hgs helps 
traffic Smad 2 and 3 to the Activin Type I receptor, allowing for different receptors to 
have specificity. This is important, as it as been demonstrated in many systems such as 
Xenopus the distribution of Smad-2 is dynamic (Lee et al. , 2004). Extracellular 
antagonists in frog embryos causes nuclear phosphorylated Smad2 to disappear. This 
suggests that constitutive cycling of the receptor, and that they are cycled back and forth 
the cell membrane in the absence of ligand. However, there is also shunting to other 
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endocytic compartments, which argues against the theory that this is a ' signalling event' . 
There is evidence that endocytosis of the receptor has a role in dampening receptor 
dependent signaling though degradation. This also would also explain how nuclear mad-
2 can 'disappear' very quickly in the early Xenopus embryo (Lee et al. , 2004). Therefore 
where within the cell the signal originates can confer additional specificity to the 
signalling process. 
The main known signal transducers ofTGF-B signalling are Smads (Massague, 
2000). There are three different subgroups of Smads: the receptor Smads, the Co-Smads 
and the inhibitory Smads. The receptor Smads are specific to the ligand/receptor 
complex, with Smad 1, 5 and 8 associating with the BMP receptors, and Smad 2 and 3 
downstream ofTGF-B/Activin receptors. R-Smads are phosphorylated by the Type I 
receptor on a conserved carboxy-terminal SSXS motif They then dissociate from the 
receptor and form a heteromeric complex with the co-Smad4 to allow nuclear 
translocation. Once in the nucleus, the Smad complex can bind with various partners to 
repress or activate gene transcription. However, the story is far more complex than 
originally thought when the Smad pathway was first identified in Drosophila and C. 
efegans (Sekelsky et al. , 1995;Raftery eta!., 1995;Savage eta!. , 1996). One classical 
example of how TGF-B signals confer specificity is the L45 loop in the TGF-B Type I 
receptors that allow them to recognize the appropriate Smads (Persson eta!. , 1998). This 
loop restrict Smads 2/3 to TGF-B/Activin receptors with only one key amino acid being 
different from the BMP Type I receptors. The R-Smads themselves also have a region to 
confer specificity, the L3 loop that is 17 amino acids long in the C-terminal domain (Lo 
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et al., 1998). If the different amino acids are 'swapped' between Smad 1 and Smad2, they 
each will respond to the other 'normal' type I receptor (Smad I to TGF -~, Smad2 to the 
BMP receptors). 
In addition to the promotion ofTGF-~ signalling, one mode of regulation of the 
signaling pathway utilizes inhibitory mads (Smad 7) to decrea e TGF-~ signalling 
(Hayashi et a!., 1997). Inhibitory Smads are turned on by TGF -~ signalling itself through 
transcription via R-Smads. This acts as a ' fine-tuning ' mechani m for signalling and 
allows signalling to be turned off after the appropriate amount of tim ha passed. 1-
Smads are thought to act via 1) direct interaction with Type I receptor to compete with 
R-Smad binding and 2) targeting receptor complexes for destruction (Schmierer and Hill, 
2007). This event requires ubiquitin ligases, Smad ubiqutination regulatory factors 1 & 2 
(SMURF 1 and 2) to tag the activated Type I receptor complex and the R- mads for 
degradation (Kavsak, 2000). Smad-7 can also interact with PP-1 to target the receptor 
complexes (Schmierer and Hill, 2007). A nuclear role for Smad-7 has been suggested, a 
Smad-7 may be able to bind Smad-responsive elements. Therefore, mad-7 may also be 
able to interfere with already active mad complexes by competing for binding to Smad-
responsive elements. 
Besides the Smad-dependent pathways, a number of Smad-independent pathways 
have been noted. TGF-~ has been shown to regulate MAPK signalling, both 
independently and through RAS, ERK, Jun and Wnt signaling (Derynck and Zhang, 
2003). As well, TGF-~ has recently been shown to activate PI3K in mesenchymal cell 
types (Wilkes eta!. , 2005) and the downstream targets p21 Activated Kinase-2 (PAK2) 
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and Akt. However, there is controversy over this pathway with different groups getting 
different results, reporting activation of Akt (Ju el al., 2005), while others see none, even 
within the same cell type (Wilkes et al. , 2005). 
TGF-13 signaling is complex, with Smad signalling being the only well-
characterized pathway. However, as the Smad signal transduction pathway appears to be 
the same in all cell types, in an effort to distinguish fibroblast and epithelial cell 
responses the rest of this review will focus on Smad independent signaling. 
Chapter 1.2.2 Smad Independent TGF -~ Signalling 
Several Smad independent pathways have been observed. Ras has been 
implicated in TGF-13 biology, with constitutively active forms ofRas interacting with 
TGF-13 signaling, and TGF-13 directly activating Ras in epithelial cells (Yue and Mulder, 
2000;Janda et al. , 2002). Other pathways that have been implicated in TGF-13 signaling 
are extracellular regulated kinase (ERK), JNK and p38 MAPK pathways (Mulder, 
2000;Yu et al. , 2002;Derynck et al., 2003;Kim et al., 2004). TGF-13 can activate p38 
MAPK in certain epithelial cultures (Yu et al., 2002). In systems with mutations in the 
TGF-13 Type I receptor that cannot activate Smads, TGF-13 still activate p38 MAPK. This 
Type I receptor is mutant in the L45 loop, so it should be activating p38 MAPK 
independently of Smads. Use of dominant negative Smads also does not interfere with the 
activation of p38 MAPK indicating this is a Smad-independent event. However, the role 
that these two pathways play in TGF-13 biology is poorly understood. Both ERK and JNK 
pathways, downstream of Ras, have been shown to phosphorylate Smads at specific sites. 
I 1 
-----------------------~----------
These phosphorylation sites cause decreased transcriptional activity and cytoplasmic 
relocalization of the Smads when phosphorylated. ERK and p38 MAPK have been linked 
to epithelial-mesynchemal transition (EMT, Bhowmick el a!. , 2001 ;Yu eta!., 2002), 
however vastly different epithelial cell lines were used in these reports and similar results 
have not been replicated in later work. Some of these reports also rely upon 
pharmacological inhibitors of p38 MAPK that can also inhibit the TGF-~ receptor 
kinases, at doses higher than 5 ~-tM (Fu eta!., 2003). As well, it is not clear that these 
events are truly Smad-independent as one group does report that Smads are required for 
EMT (Yu et al. , 2002). 
Along with ERK, TGF-~ activates the Rho-like GTPases, Rho A, Racl and cdc42 
(Edlund, 2002). Typically, the activation of these proteins has been linked to PI3K and 
cytoskeletal reorganization downstream of receptor tyrosine kinases (RTKs). When 
activated by TGF-~, they have been linked to cytoskeletal reorganization and EMT. 
There has also been a report that the LIM1 kinase can interact with the cytoplasmic tail of 
the BMP Type II receptor, and this receptor can phosphorylate LIMK1 directly (Foletta et 
a!. , 2003). LIMKl kinases regulate the small G protein family, Rho, and are involved in 
actin cytoskeleton reorganization. The small GTP' ase Cdc42 is required for activation of 
LIMK1 after BMP stimulation. LIMK1 can then translocate to the nucleus and repres es 
Rac/CDC42 dependent Cyclin D 1 expression. Experiments in Drosophila with Dpp al o 
indicate that DCDC-42 and dPAK are activated in response to Dpp signaling, but LIMK1 
may or may not be involved (Ricos et al. , 1999). A key question is whenever the c-
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terminal tails of other Type II receptors can signal with LIMKl , and is an open question 
with regards to TGF-13 biology. 
A potential downstream target of Rae 1/cdc42, is the p21-activated kinase (PAK2). 
TGF-13 has been shown to specifically activate PAK2 in a subset of fibroblast cell lines, 
but not epithelial cells in a pathway that requires cdc42 (Wilkes eta/., 2003). This event 
was shown to be independent of Smad signaling and dependent on TGF-13 receptors. 
Abolishment of PAK2 leads to defects in TGF-13 mediated growth and morphological 
transformation (MT) in these fibroblast cultures. A more recent report (Wilkes et al. , 
2005) has linked TGF-13 to both PI3K and PAK2 in a linear pathway, giving a clear 
signaling mechanism of how TGF -13 exerts its action upon P AK2. 
A link between TGF-13 and PI3K signaling pathways in invertebrates was first 
established in 1997, with the discovery that there was a genetic interaction in C. elegans 
between Daf-7 (a TGF-13 ligand homologue) and Daf-16 (FOXO homologue, Ogg ef al., 
1997). A role for PI3K has also been described in EMT of epithelial cultures downstream 
of TGF-13 and in preventing apoptosis of epithelial cultures through activation of the 
PI3K target, Akt (Bakin et al., 2000;Shin eta!., 2001). One of the major issues with 
Smad-independent signalling is exactly how TGF-13 receptors are able to couple to PI3K. 
PI3 Kinases are traditionally activated by receptor tyrosine kinases, and TGF-I3's are 
serine/threonine kinases. TGF-13 has been linked to PI3K activation indirectly in well 
over 300 papers and counting in Pubmed, but there are only a few reports that address the 
issue. Yi et al. (2005) irnmunoprecipitated the PI3K p85 subunit from TGF-13 treated 
cells and found that this subunit could increase PIP3, pAkt and pErk after 1 hour of 
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stimulation. When COS-7 fibroid cells were transfected with p85 subunit and TGF-~ 
Type I and II receptors, the authors were able to always pull-down p85 with the Type II 
receptor, and only in the presence of ligand in the case of the Type I receptor. To assess 
whenever this was a direct interaction, in vitro assays with p85 and the Type I and II 
receptors were undertaken. In this assay, only the Type II receptor could bind p85, 
suggesting that the Type I receptor requires some cofactors or adaptor proteins to bind 
PI3K. Kinase deficient Type II receptor disrupts endogenous binding of PI3K to the Type 
I receptor, and the Type I receptor kinase activity seems to be essential for PI3K kinase 
activity, as assayed by pAkt. 
These findings are somewhat supported by a report by Wilkes et al. (2005) which 
demonstrates that TGF-~ activates PI3K in mesencyhmal cultures. In fibroblasts, p85 was 
immunoprecipated from TGF-~ treated cells and resulted in increased kinase activity 
against PIP. Activation ofpAkt at Serine 473 and Theronine 308 was also observed. The 
findings of Yi were also extended in that inhibitors of transcription and translation didn' t 
prevent Akt phosphosrylation, suggesting this is a transcription factor independent event. 
Knockdown of p85 by morpholino also prevented Akt phosphorylation in the fibroblast 
cells. However, in the Wilkes paper, there was no activation of PI3K seen in epithelial 
cells, which is in conflict with the Yi report. 
This increased activation ofPI3K has been shown in fibroblastic cell lineages as 
well as epithelial cultures as demonstrated by the above reports (Kim et al. , 2002). 
However, especially with epithelial cultures, several groups fail to show "activation" of 
Akt when stimulated with TGF-~ in epithelial cells (Conery eta/. , 2004;Seoane et al. , 
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2004;Wilkes et al., 2005). To clarify this issue, one of the major goal of this thesis will 
be to further define the interaction ofTGF-B with Akt and some of it's downstream 
targets. 
Chapter 1.3 PI3K Signalling Pathways 
Many extracellular signals control the delicate balance between cell survival and 
cell death (Brazil and Hemmings, 2001). These signals can function by activating 
phosphatidylinositol 3-0H kinase (PI3K), an enzyme that catalyzes the addition of a 
phosphate group to the inositol group of phospholipids. One of the first ligands shown in 
activation of PI3K was Insulin. However, PJ3K has been shown to be activated by several 
growth factors other than Insulin (Lawlor and Alessi, 2001) such as Epidermal Growth 
Factor (EGF), Insulin-like Growth Factors (IGF-1 , 2), Nerve Growth Factor (NGF), 
Vascular Endothelial Growth Factor and Platelet Derived Growth Factor (PDGF, Brazil 
et al., 2001). All of these growth factors have been implicated in human health and 
disease, with EGF (Her-2/Neu) being particularly relevant to female specific cancers, 
such as breast and ovarian cancer. In Drosophila, PI3K has been shown to be activated by 
the insulin-like pep tides (DILPs, Brogiolo et al. , 2001 ). All of the e ligands have known 
receptors, such as the EGF receptor and the insulin receptor. Most of the receptors known 
to activate PI3K are RTKs, although some G-protein coupled receptors such as the 
endothelin receptor can also activate PI3K (Brazil et al., 200 I). RTKs once activated, 
dimerize, and undergo an auto-transphosphorylation event at a nwnber of tyrosine 
residues. Through these phosphotyrosines, downstream proteins recognize the activated 
receptor. The p85 regulatory subunits of PJ3K (p60 in Drosophila) ha e an Src homology 
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2 domain (SH2) that recognizes these phosphorylated tyrosines. However, the affinity of 
p85 for RTKs are helped by a class of molecules called adaptor proteins (Zhang and 
Samelson, 2000). Adaptor proteins are proteins that do not contain motifs for 
transcriptional activity or kinase activity. Instead, they are made of motifs designed to 
recognize phospho-tyrosine YxxM motifs, such as SH2 and SH3 or phospho-tyrosine 
binding (PTB) domains. Some examples of adaptor proteins that help PI3K bind to EGFR 
are Gab, Sos and Grb. For the insulin receptor, PI3K activation is enhanced by the 
adaptor protein, insulin receptor substrate 1-4 (IRSl-4, Folli e/ a!. , 1992-Lawlor e/ a!. 
2001 ). Once bound either directly or by the help of adaptor proteins, p85 recruits and 
activates the catalytic p II 0 subunit (V anhaesebroeck et al. , I997). The removal of these 
growth factors from culture medium results in the inactivation of PI3K, thus apoptosis or 
cell cycle arrest due to the cell survival pathway of PI3K/ Akt being no longer active. 
Activation of PI3K by the relevant RTK leads to the subsequent activation of Akt 
and other kinases through membrane lipid phosphorylation (Leevers et a!. , 1996;Chan et 
a/., I999). There are three classes of PI3 Ki nases, the Class 1 AlB Class 2 and Class 3. 
PI3Ks are classified based on which Ptdlns they phosphorylate in vitro, with class lA 
PI3Ks also showing a preference for Ptdlns( 4,5) bisphosphate , in vivo (V anhaesebroeck 
et al. 1997). Since only the PI3K 1 A kinases activate Akt, these will be further discussed. 
PI3I A kinases are lipid/protein kinases composed of heterodimers which consist of a 
regulatory subunit (p85) and a catalytic subunit (p 11 0) (Vanhaesebroeck eta/., 1997). 
The p85 subunit SH2 domain binds to the phosphorylated tyrosines ofRTKs in the 
plasma membrane. This binding localizes the PI3K from the cytosol to the membrane, the 
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location of the kinase's lipid substrates. The assembled kinase then phosphorylates the D-
3 position on the ring of inositol lipids to generate phosphatidylinositol 3-phosphate 
(PIP), phosphatidylinositol (3,4) bisphosphate (PIP2) and phosphatidylinositol (3 ,4,5) 
triphosphate (PIP3) from Ptdlns, Ptdlns(4)P and Ptdlns(4,5)P2 respectively. The 
phosphorylated lipids can then be bound by pleckstrin homology (PH) domains on 
various downstream proteins (Chan et a!. , 1999) such as cdc42/Rac 1, Phosphoinositide-
dependent kinase I (PDK-1), Intergrin Linked Kinase (ILK) and Akt. 
Chapter 1.3.1 Akt 
Akt is a serine/threonine kinase that is activated by the activity of PI3K (Datta et 
a!. , 1996;Lawlor et al. , 2001 ). The Akt protein contains a PH domain at its N-terminus, a 
glycine rich domain and a serine/threonine kinase domain. It also contains two regulatory 
phosphorylation sites, located at threonine 308 and Serine 473 of Aktl , with similar sites 
in Akt2 and Akt3 (Brazil et al., 2004). Drosophila melanogaster has one form of Akt 
(Dakt) (Stave ley et al. , 1998), while mammals have 3 isoforms (Akt 1, 2, and 3). Akt is 
activated by phosphorylation at the key residues, Akti Thr308 and Aktl Ser473 as illustrated in 
Figure 2 (Brazil et al., 2004). It is phosphorylated by PDK 1 at Akt1 Thr308 (Rintelen eta!. , 
2001). 
The identity of the kinase that has Phosphoinositide-dependent kinase-2 (PDK-2) 
function remains controversial (Chan and Tsichlis, 200 I). A number of kinases may 
phosphorylate at Akti Scr473, such as autophosphorylation by Akt itself, but this PDK2 
function is elusive, as none has been shown conclusively in vivo (Chan eta!. , 2001 ). 
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Growth factor 
Inactive 
PKB 
Figure 2: An overview of Akt activation by PI3K. 
Active PKB 
Growth factors bind to receptors, and recruit PBK to the cell membrane. PBK 
phosphorylates Ptdlns(4,5)P2 give Ptdlns(3,4,5)P3. This recruits PDKl and Akt to the 
membrane, where PDKl phosophorylates residue Thr 308. An unknown kinase 
phosphorylates Ser 473. Once activated, Akt dissociates for the cell membrane to 
phosphorylate substrates (FOXO) in the cytosol and nucleus. This figure was adapted 
from Brazil and Hemmings, 2001. 
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An essential role for Intergrin Linked Kinase (ILK) in erine 473 phosphorylation has 
been demonstrated by RNA interference, however fibroblast from ILK-knockout mice do 
not appear to have reduced Serine 473 phosphorylation when compared to wild-type 
(Attwell, 2003; Shioi et al. , 2002). Target of rapamycin (TOR) kinase and its a sociated 
protein rictor is another potential Serine 473 kinase (Sa.rtbassov eta!., 2005) in cell 
culture, however this has not been demonstrated in vivo. As the controversy suggests, 
there role of PDK-2 may be assumed by a number of kinases depending on the cellular 
and developmental context. 
PDKl is activated by the presence of Ptdlns (3, 4, 5) P3 produced by the action of 
PI3K. Binding of the lipid to PDKl ' s PH domain, causes recruitment to the cell 
membrane (Rintelen et al. , 2001 ), resulting in a conformational change that activates 
PDKl. Phosphorylation on the activation loop site Serine24 1 is also necessary for 
activation of PDK-1 and appears to be an autoactivator event (Casamayor et al., 1999). 
As well, PIP3 interacts with the PH domain of Akt, to colocalize Akt and PDKl to the 
plasma membrane. Akt is phosphorylated within its p-loop domain containing Thr308 by 
PDK. This activation process following ligand binding can be quite rapid, and activation 
of Akt occurs maximally within a few minutes, as in the cause of EGF (Burgering and 
Coffer, 1995). This contrasts with growth factors such as insulin, that maximally induces 
Akt phosphorylation after about 90 to 120 minutes after ligand stimulation (Ueki et al. , 
1998), suggesting multiple ways of activating Akt through the common mechanism of 
PI3K activation. 
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Chapter 1.3.3 Downstream targets of Akt 
Once activation occurs, Akt dissociates from the plasma membrane and moves 
into both the cytoplasm and nucleus where it can act upon its substrates (Burgering and 
Medema, 2003). Many of the effects of Akt on cell cycle may be through the inactivation 
of components of cell cycle inhibitory pathways, such as p21 CipJ and p27Kip l (Liang eta!. , 
2002). The effects of Akt on cell survival may be through the inactivation of components 
of apoptotic pathways, such as the phosphorylation of Bcl-2 pro-apoptotic fami ly 
member (BAD, Datta eta!. , 1997). The phosphorylation of BAD results in its binding to 
14-3-3 protein. This prevents BAD from interacting with Bcl-xL, thus preventing 
induction of apoptosis. In addition, Akt phosphorylates the inhibitor of NFKB kinase-a 
(IKKa, Brazil eta/., 200 1). As the name suggests, IKKa inhibits nuclear factor KB 
(NFKB) under normal circumstances. When phosphorylated by Akt, IKK is inactivated, 
allowing NFKB to act as a transcription factor for induction of cell survival genes. 
A very important target of Akt activity is glycogen synthase kinase-3 (GSK-3). 
originally identified as a protein involved in glucose metabolism (Doble and Woodgett, 
2003). This protein is a serine/threonine kinase with many diverse substrates in the cell. 
There are two isoforms of GSK-3, a and ~' in mammals. Both isoforms are simi lar in the 
kinase domain, however different in other parts of the protein. There is one isoform in 
Drosophila termed Shaggy or Zeste-White 3 (Park eta!. , 1998). The two mammalian 
isoforms appear to phosphorylate similar substrates. However, the generation of GSK-
knock-out mice demonstrates these proteins are not redundant. The GSK-3~ knockout 
was embryonic lethal due to massive apoptosis of liver cells. This defect could not be 
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rescued by the overexpression of GSK-3a (Hoeflich et a/. , 2000). A mo t of the 
literature has described GSK-3~ substrates, we chose to focus on this isoform. 
GSK-3~ has several phosphorylation sites that are involved in the regulation of 
the protein. This includes one at the c-terminu (T-loop), GSK-3~Tyr2 1 6, that is 
constitutively phosphorylated and thought to be necessary for the acti ation of the 
protein. Interestingly this site has been shown to be necessary for substrate 
phosphorylation, but does not affect kinase activity (Dajani et al. , 200 I). ince GSK3 
shows a strong preference for ' primed ' substrates, ones that have already been 
phosphorylated upstream of the GSK3 recognition sites, perhaps this ite i necessary for 
the recognition of these substrates. Variations of phosphorylation at this site have been 
noted in different cell types (Papadopoulou eta/. , 2004), and knocking this site out in 
Drosophila eliminates function of the protein. However, the main mechanism of GSK-
3~ regulation is the phosphorylation of the serine residue located at po ition 9. 
Phosphorylation at G K-3~ er9 is an inhibitory event, preventing kinase activity by 
preventing the protein from binding substrate (Cross et a!. , 1995), and this is the site that 
is phosphorylated by Akt. 
Active G K-3~ has numerous substrates that are involved in gen tran cription. 
Phosphorylation of these substrates results in their inactivation, thus regulating cellular 
events such as growth, protein translation, cell cycle and apoptosis. In addition to 
regulation by direct phosphorylation by Akt, GSK-3~ is functionally regulated by Wnt 
signalling (Patel et al. , 2004). After Wnt ligand binding, the protein Dishe elled causes 
GSK3~ to be inactivated through an unclear mechanism, perhaps involving the APC 
complex (van Noort et al. , 2002a). This places G K3~ downstream of both PI3K and 
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Wnt signalling, allowing for potential cross-talk between the two pathways. However, at 
least in some cell types, insulin inhibits GSK3~ activity but has no effect on Wnt 
signalling indicating the two pathways intersecting at GSK3~ may be functionally 
distinct (Doble et a!., 2003 ). One of the best -characterized components of Wnt signalling 
is ~-Catenin, a tumour suppressor that can induce transcription ofCyclin Dl. GSK-3~ 
can phosphorylate ~-Catenin leading to proteosomal mediated degradation of the protein 
(van Noort et al., 2002b). However, the impact of Akt in affecting ~-Catenin appears to 
depend on cell type and context. GSK-3~ can also phosphorylate eiF2B, as well as c-
myc. These transcription factors upregulate the expression of many cell cycle proteins, 
notably Cyclin D 1 (Doble et al. , 2003). In addition to these effects on Cyclin D 1 
transcription, GSK-3~ has been shown to directly modulate Cyclin D1 by 
phosphorylation at a threonine located at site 286 (Diehl et a!. , 1998). This 
phosphorylation in NIH-3T3 cells was shown to decrease the stability of Cyclin D I 
(increasing the protein turnover rate by 50%), complex formation with CDK-4/6 and the 
nuclear localization ofCyclin Dl. An interesting finding was that GSK-3~ recognizes 
Cyclin Dl best as a substrate when it is complexed with its CDK binding partner. This 
suggests that GSK-3~ ha a direct effect on cell cycle progression. 
GSK-3~ also has effects on Tau and Presenilin 1, two proteins known to be 
involved in Alzheimer' s disease pathology (Doble eta!. , 2003). The Drosophila 
homologue, Shaggy, has been shown to hyper-phosphorylate tau and induce 
neurofibrillary tangles in a Drosophila model of Alzheimer' s disease, consistent with the 
notion that hypo-phosphorylation of Tau leads to some of the disease state phenotypes 
(Jackson et al. 2002). To date, the only well-characterized substrates of Shaggy are Tau 
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and ~-Catenin, and these have been studied strictly with regard to Wingless/Wnt 
signaling (Rue! el al., 1999). It has been postulated that Shaggy acts downstream of 
dPI3K/dAkt, in a similar fashion to mammals (Staveley, personal communication), 
however no group has shown this to date. 
Another disease state that GSK-3~ has been implicated in is cancer development, 
through its regulation of the previously described substrates, and more recently nail. The 
nail transcription factor was originally identified in Drosophila as an EMT transducer, 
and has since been implicated in human cancer (Peinado et al., 2003). G K-3~ 
phosphorylates Snail at two sites, inducing nuclear relocalization and degradation of the 
protein to prevent EMT in epithelial cells. Interestingly, a report ha demonstrated a link 
between Snail and TGF-~ (Peinado et al. , 2003). nail protein levels are increased upon 
TGF-~ stimulation in epithelial cells and Snail has been implicated in TGF-~ mediated 
EMT via an unknown mechanism. 
An additional downstream target of Akt is the transcription factor, FOXO 
(forkhead box, sub-group "0") or FKHR (forkhead in rabdomyosarcoma), which are part 
of a larger group of transcription factors termed the Fox family (Brunet, 2004). There are 
four isoforms ofFOXO in humans, FOXOl , 3a, 4 and 6 (van der Heide el al. , 2004) and 
one in Drosophila, dFOXO (Kramer el al. , 2003). FOXO is a member of the winged helix 
transcription factor family and contains a nuclear localization signal (NLS), a nuclear 
export signal (NES), Akt phosphorylation sites and a forkhead box DNA binding domain 
(Tran et al., 2003 ). Akt can phosphorylate FOXO 1 at three specific sites, FOX 1 thr24, 
FOXO 1 ser256 and FOXO 1 ser319. Upon phosphorylation, FOXO is then excluded from the 
nucleus and is sequestered in the cytoplasm by a 14-3-3 binding protein. If Akt is 
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inactive, then FOXO remains in the nucleu where it induces transcription of a number 
of target genes. 
FOXO causes the transcription of several factors that lead to control of cell cycle, 
such as p27Kir'. As FOXO was originally identified as a tumour suppres or gene in 
human sarcoma, the regulation ofthese gene may be how loss of this protein promotes 
cancer. To facilitate G 1 arrest, FOXO upregulates transcription of the Cycl in-Dependent 
Kinase Inhibitor p27Kipl (Burgering et al., 2003) and inhibits transcription of other factors 
such as Cyclin D 1 ( chmidt et al., 2002). FOXO is also involved in the G2/M phase of 
the cell cycle via the transcription of G 0045 (Furukawa-Hibi et al. , 2002; Tran et al. , 
2002). GADD45 is a DNA repair protein and FOXO may help stall the cell at 2/M after 
oxidative stress to allow DNA repair to occur. In addition to these effects on cell cycle, 
dFOXO has been shown to influence growth and nutrition in Drosophila (Giannakou et 
al. , 2004) 
Overexpression of dFOXO induces smaller cell size and also decrea es number of 
cells in the fly eye (Kramer et al. 2003). DAkt re cues the dFOXO smaller cell size 
phenotype, supporting the idea that DAkt regulates growth through dFOXO. 
Overexpression of the dFOXO phenotype is rescued by dRAS in the eye. However, no 
effect was seen with EGF, suggesting that dFOXO mediates growth through inhibition of 
cell cycle and not apoptosis. Akt, and its dir ct downstream target, FOXO, therefore 
function in the direct control of both growth regulation and cell cycle 
Chapter 1.4 Cell Cycle Proteins 
An important input into cell growth is the control of the cell cycle. In embryonic 
cell lineages, the cell cycle is short, with and M phases being dominant with little time 
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spent in the 'Gap' phase (Sherr, 2000a). As cells differentiate into their final fates, the 
two Gap phases (G 1 and G2) become crucial for cell cycle control. In the first ' Gap' 
phase, or G 1, the cell increases size and "measures" nutrient availability to ensure 
sufficient resource to synthesize DNA and make a daughter cell. Therefore, this part of 
the cell cycle is controlled by many mitogenic signals or growth factors allowing the start 
of the cell cycle to be coupled to metabolic and out ide inputs. 
Indeed, many differentiated cells do not divide (e.g. neurons), entering a ' Go' 
stage either temporary or indefinitely. In order for a cell to escape ' Go' or senescence, 
some form of initiation factor must be applied. These initiation factor mainly cause the 
increased transcription/synthesis ofthe D type family ofcyclins (Sherr, 2000b). Cyclins 
are proteins that by themselves have little activity, but when bound to yclin-Dependent 
Kinases (CDK) in a heterodimer, create an active prot in kinase (Ma sague, 2004). The 
CDKs are regulated by phosphorylation, but it is mainly the protein interaction with the 
cyclins that determines functionally. The CDK binding partners for the D family of 
Cyclins are CDK-4 and 6. The prototype of the D family is Cyclin Dl that mainly binds 
to CDK-4. The major physiological substrate of this complex is the retinoblastoma 
protein (Rb, Zhang and Dean, 200 I). Rb is a tumour suppressor that regulates th E2F 
transcription factors. Binding of Rb either turns the 2Fs into transcriptional repressor 
proteins (E2F4, 5) or inactive transactivators of transcription (e2F 1 2, 3), thereby 
eliminating their respective functions (Zhang eta!. , 1999). Transcription of the Cyclin E 
gene requires functional E2F transcriptional factors. Increased Cyclin levels ar needed 
to make functional Cyclin E-CDK2 complex. Therefore, Cyclin Dl /CDK4 complexes 
function to inactivate Rb, thereby releasing E2F to induce Cyclin E and other genes 
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involved in DNA synthesis. Active Cyclin E-CDK2 complexes phosphorylate the 
remaining Rb, allowing for entry into S phase. 
In this model of the cell cycle, a cell that has any stimulation with growth facto rs 
will replicate. This is not necessarily the case, since the cell can regulate the timing and 
control of cell division indicating many inputs into this process (Sherr, 2000b). It is 
known that the expression and formation of the Cyclin/CDK complexes are tightly 
regulated processes that occur only at a very specific time in the cell cycle. To increase 
the ability of the cell to regulate Cyclin/CDK activity, there are CDK-inhibitors that 
block complex formation. They are p27Kipl ' pJ4ink4b, p161NK-Ia and p21 Cipt!Waft. The main 
inhibitor of the cyclin E/CDK2 complexes is p27KipJ and forced expression of thi s protein 
can halt the cell cycle (Sherr and Roberts, 2004). However, there are several mechanisms 
by which mitogenic stimuli can inactivate p27, either at the transcriptional/translational 
level or by direct phosphorylation. Phosphorylation of p27 decreases stability of the 
protein and causes nuclear exclusion. Surprisingly, p27 has also been shown to be present 
in Cyclin Dl/CDK complexes, and the presence ofp27 appears to help complex 
formation (Polyak eta/. , 1994;Reed, 2002). Therefore, Cyclin Dl /CDK 4-6 complexes 
function in the cell cycle by mopping up any excess p27 so that Cyclin E/CDK2 can 
become active. Once this Cyclin E/CDK 2 complex is active, it will phosphorylate p27, 
ultimately driving the ceU through the G liS checkpoint. 
Chapter 1.5 Experimental Rationale 
Both TGF-~ and PI3K/Akt pathways regulate the cell cycle (Liang eta/., 2002), 
with Akt, in addition to the previously mentioned targets, directly regulating the 
phosphorylation ofp27kipt and p21 cipt, which causes degradation and nuclear exclusion of 
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these proteins (Fujita et al. , 2002). In a report by Seaone et a!. , (2004), Smad 2/3 was 
shown to cooperate with FOXO transcription factors to induce p21 cipl gene expression in 
cells of epithelial origin. This report links the TGF-~ and PI3K signalling pathways 
together in the control of a cell cycle gene. In Drosophila, nutritional signals can 
activate quiescent larval tissues to enter the cell cycle and continue larval growth (Britton 
and Edgar, 1998). As well, ectopically expressing genes known to contribute to the cell 
cycle can stimulate growth. Mutations in the insulin signalling components chico, dlnR , 
DpllO, PDKl , Akt and dS6K results in smaller flies (Leevers et al. , 1996;Goberdhan et 
al. , 1999;Verdu et al. , 1999;Rintelen et al. , 2001). Overexpression ofDpllO (dPI3K) 
increases cell size, but not cell division rates (Leevers et al. , 1996). Work by Staveley et 
al. , ( 1998) illustrates that mutations in DAkt cause ectopic apoptosis and smaller body 
size. In parallel to the insulin pathway, mutations in Baboon, the TGF-~/Activin TGF-~1 
receptor, result in reduced size of nervous system imaginal discs and overall organ size, 
without increasing apoptosis (Brummel et al. , 1999) This suggests that the effects of 
PI3K/Akt and TGF-~ are linked in the control of cell cycle, as this is an integral part of 
cellular growth. 
A major goal of this research is to investigate the molecular signalling pathways 
and physiological roles ofTGF-~. As outlined above, TGF- P has been shown to activate 
SMADs to exert its effects and also interacts with PI3K pathways via an unknown 
mechanism. One of the goals of this project is to further characterize the interaction of 
TGF- p signalling with Akt. We will also study two direct targets of the protein kinase 
Akt, FOXO and GSK-3p. 
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A major theme of this research is to determine why different cell types respond in 
very dissimilar fashion to TGF-~. Epithelial and immune cells are growth inhibited by 
TGF- ~' whereas mesenchymal cells are growth simulated (Massague, 2000). Prior to this 
research, both categories of cells appear to activate identical receptors and the same 
downstream intracellular pathway (SMADs). Therefore, I am looking for differences in 
the PI3K pathway between fibroblast (mesenchymal cells) and epithelial cells. 
In addition to the studies that will be undertaken in cell culture, I will also try to 
determine a genetic interaction in Drosophila melanogaster. Since overexpression/null 
alleles of many PI3K pathway components and TGF-~ receptors cause viability problems 
in whole flies, I will study the interactions in the compound eye. The Drosophila 
compound eye is an excellent model for studying cell growth/developmental genes due to 
its highly organized structure of ommatidia. Using UAS/GAL4 system of ectopic gene 
expression in the eye through the regulation of the eye specific promoters GMR and 
eyeless, we can study the genetic interactions of Baboon (TGF- PI Activin like TGF-~II 
receptor) with components ofPI3K signaling. I will examine this genetic interaction 
using scanning electron microscopy (SEM). These experiments will determine if there is 
an interaction with dFOXO, dPI3K, dAkt and Shaggy (GSK-3~) with the Baboon 
receptor. 
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Chapter 2 Materials and Methods 
2.1 Cell Culture 
All cell cultures was performed at 3 7°C in a 5% C02 humidified atmosphere. 
Two phenotypically normal fibroblast cell culture lines (AKR-2B and NR.K-49) were 
grown in high-glucose Dulbecco's modified Eagle medium (DMEM, Invitrogen, Canada) 
supplemented with 10% fetal bovine serum (FBS). NIH-3T3 fibroblasts grown in high 
glucose DMEM were supplemented with 10% Normal Bovine Calf Serum (NBCS). Two 
phenotypically normal epithelial lines (mink lung epithelium, Mv1Lu and a mouse 
mammary gland epithelium, NMuMG) were grown in DMEM/1 0% FBS, with the media 
ofthe NMuMG line supplemented with 10 ~-tg/ml bovine insulin (Sigma) and 5 ng/ml 
recombinant human EGF to promote growth and prevent differentiation. Chimeric 
receptor expressing clones have been described previously (Anders and Leof, 1996; Dore 
et al. , 2001). Briefly, the ligand-binding domain ofGM-CSF was fused to the TGF-~ 
transmembrane and cytoplasmic domain to create receptors that respond to GM-CSF with 
a TGF-~ signaling cascade. I utilized three lines, as outlined in table 1: 1) Contains both 
normal Type I and Type II TGF-~ receptors , 2) Type I kinase dead (K232R) with a 
normal Type II TGF-~ receptor or 3) Type II kinase dead (K227R) with a normal Type I 
TGF-~ receptor. This allows for use of the endogenous TGF-~ receptors as a control, as 
the chimeric receptors do not interact with the normal TGF-~ receptors. Chimeric AKR-
2B fibroblast lines were maintained in 10% FBS in McCoy ' s SA medium (Invitrogen, 
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Table 2: Characteristics of TGF -B chimeric receptor lines 
Clone 
AHM-4 
A708 
A618 
Cell Type 
Fibroblast 
Fibroblast 
Fibroblast 
Inactivating Mutation 
Express Normal Chimeric receptors 
Type I Kinase Dead (K232R) 
Type II Kinase Dead (K227R) 
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Canada) and supplemented with I 00 f.Ag/ml geneticin and 50 f.-lg/ml hygromycin B (Sigma 
Canada) to maintain the chimeric receptors expression. Fibroblast cell lines were plated 
at 1.5x I as cells per well in each well of a six well dish in growth media and allowed to 
attach for 24 hours. They were serum deprived ovemight in O.I% NBCS/DMEM prior to 
treatment with TGF-~2 (I-5 ng/ml) for indicated time periods (0-6 hours). For epithelial 
cells, Mvi Lu were plated at 3.0xi 05 cells per well , allowed to attach for 24 hours and 
treated as indicated. NMuMG cells were plated at l.Ox I as per well in six well plates, 
allowed to attach for 24 hours, growth factor deprived for ~I6 hours in DMEM/10% FBS 
and treated as indicated. Inhibitors used in this study were dissolved in DMSO and stock 
solutions were stored at -20°C and protected from light. L Y290004 (Cell Signalling, 
Invitrogen, Canada) was used at a final concentration of 10 f.AM (lOmM stock), and Akt 
inhibitor IV (Calbiochem, USA) was used at a concentration of 1 f.AM (stock 1 mM). 
2.2 Protein Extraction 
After cells were treated for the indicated time periods, plates were placed on ice 
and wells were washed 3x in ice-cold PBS. Total cellular protein was obtained by lysing 
cells in a modified ice-cold RIPA buffer (PBS, 50 mM Tris-HCl pH 7.4, 0.5% Sodium 
deoxycholate, I% Triton X-1 00, O.I% SDS, 50 mM NaF, 50 mM ~-Glycerol -phosphate, 
5 mM EDT A, 100 f.AM Na3 Y04, 50 f.!g/ml of phenylmethylsulfonyl fluoride and 1 X 
Complete protease inhibitor cocktail [Roche Canada]) for 5 minutes on ice. Cellular 
lysates were then collected using cell lifters (Fisher Canada) and transferred into l.5ml 
microcentifuge tubes. Cellular debris were pelleted by centrifugation at 21 ,OOOx g for 10 
minutes at 4°C and supernatant was transferred to a new 1.5ml microcentifuge tube. Cell 
lysates were then stored at -80°C. 
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Nuclear and cytoplasmic extracts were prepared (N-PER, Pierce) as described by 
the manufacturer's protocol from AKR-2B and NMuMG cells treated with 2ng/ml TGF-
~2 to assay Cyclin D 1 distribution using Western blotting. Total protein in all samples 
was determined using the BCA protein assay kit (Pierce) according to the manufacturer' s 
protocol and read at 562 nm on a Polar Star plate reader (BMG Inc) using bovine serum 
albumin as a standard. 
2.3 Immunoprecipitation 
Protein was extracted from MuMG and AKR-2B as described previously in a 
RIPA buffer modified for imrnunoprecipitation (1 x PBS, 50 mM Tris-HCI pH 7.4, 1% 
Triton X-100, 50 mM NaF, 50 mM Glycerophosphate, 10 mM DTA, 1 mM a3V04, 
50 Jlg/ml of phenylmethylsulfonyl fluoride and I x Complete protease inhibitor cocktail). 
Equivalent amounts of total protein were diluted with fresh IP buffer to an equal final 
volume, and monoclonal anti-Cyclin D 1 (Cell Signalling) was used to imrnunoprecipitate 
the protein overnight ( - 16 hours) at 4°C on a rocker platform. Protein G-sepharose 
(Pierce) was added for 2 hours with rocking to collect the antibody/Cyclin Dl complexes. 
Protein G/ Antibody complexes were centrifuged at 8000x g for 1 minute to pellet the 
epharose beads. Supernatant was aspirated using a 27g needle to prevent bead loss, and 
the Protein G/ Antibody complex was washed ice-cold IP buffer rocking at 4° for 10 
minutes. This was repeated 3x, followed by one wash with PBS. Samples were then 
resuspended in 2x E lectrophoresis sample buffer, vortexed, and heated for 3 minutes at 
1 00°C. Samples were separated by SD -PAGE, and then transferred to PDVF membrane 
and co-precipitated CDK-4 detected using an anti-CDK-4 antibody (Cell ignaling) to 
determine the amount of CDK4/Cyclin D 1 complex formation. 
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2.3 Western Blotting 
Electrophoresis sample buffer (5x strength, 5% SDS, 150 mM Tris HCL pH 6.8, 
5% glycerol, 5% ~-mecaptoethanol and 0.125% Bromophenol blue) was added to each 
protein extract and boiled for 3 minutes. Equivalent mass of total protein sample was 
then resolved on the appropriate 8.5 or 12.5% acrylamide gel in either a Protean II 
minigel apparatus (BioRad) or an ADT-26 gel apparatus (Owl Scientific). Gels were 
transferred for 1 hour at 100 volts using a Transblot apparatus (BioRad) to either PDVF 
or Nitrocellulose membranes and specific proteins were detected with antibodies as 
indicated. Immune complexes detected using HRP-conjugated species-specific antibodies 
(Santa Cruz, HRP-anti-mouse or HRP anti-rabbit) followed by ECL detection (Pico 
Supersignal, Pierce). Specific protein from each sample was probed with a phospho-
specific antibody (Akt Serine 473, PDK-1 Serine 241 , GSK-3~ Serine 9, Cyclin Dl 
Theronine 286, Cell Signalling), stripped for 30 minutes at 5 5°C in buffer (1 OOmM 2-
mercaptoethanol , 2% SDS, 62.5mM Tris-HCl pH6.5) , and tested with the corresponding 
antibody for total specific protein (PDK-1 , Akt, Cyclin D 1 (DC6) Cell Signaling or G K-
3~, Cyclin Dl , Santa Cruz). Other antibodies used in this studied were CDK-4 (Cell 
signaling). 
2.5 Morphological transformation 
AKR-2B cells were plated at 2.5x105 cells per well of a six well dish, allowed to 
grow to confluence and then treated with serum-free Iscove 's medium (Invitrogen, 
Canada). After 48 hours, either medium alone was added or medium containing inhibitors 
(Akt inhjbitor IV, Calbiochem) with or without 5ng/ml TGF-~2 as indicated for an 
additional 48 hours, with fresh inhibitor and TGF-~ being added at 24 hours. After 
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treatment, cells were washed 2x with room temperature PBS and fixed for 30 minutes at 
4 degrees C in 4 % Paraformaldehyde (PF A) in PB . After fixation, cells were washed 
once in PBS, permeabilized in 0.5% Trition in PBS for 90 seconds, then washed twice fo r 
5 minutes with PBS. FITC-conjugated phalloidin ( igma, Canada) was then added for 40 
minutes at a dilution of 1/500 and cells were washed extensively in PBS. Images were 
captured using a Leica DMRJEZ inverted microscope using a 20x Pau Lyedtide 
brightfield phase contrast optics while fluorescence images of phalloidin stai ning used an 
L5 filter set. 
2.6 Growth Assays 
Growth assays were undertaken as previou ly described (Wilkes el a/. , 2003) with 
minor modifications. Briefly, NIH-3T3 cells were plated at 50,000 cells per well, allowed 
to attach 24 hours, serum deprived in 1% NBCS/DMEM for 24 hours. This medium was 
r placed with medium containing 5 ng/ml TGF-~ with or without Akt IV inhibitor. After 
incubation for I8 hours, H3 -thymidine ( I f,lCi) was added for 2 hours. The assay was 
stopped by washing cells 2x for I 0 minutes with 4°C 10% TCA and H3 -thymidine 
incorporation determined by solubilizing the precipitated DNA with 0.2M NaOH, 0.2 
mg/ml sheared salmon sperm D A and counting an aliquot (I 00f,ll) in a scintillation 
counter (Beckman). 
2. 7 Drosophila Culture 
Flies were cultured on standard cornmeal/molasses/yeast media. All experiments 
were done at 25°C. We utilized the UA /Ga14 system of ectopic gene expression (Phelps 
and Brand, 1993) for misexpression in the developing eye, and Table 2 illu trates the 
corresponding fly and mammalian names. Glass multiple reporter (GMR-Gal..f)!cyo 
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females were crossed to UAS-dActivin-{3 dsRNA.HL I UAS-dActivin-{3 dsRNA.HL and UAS-
babo/ UAS-babo and wlll8 (Control) males. Eyeless- Gal4/cyo, Eyeless-Gal4,· UAS-HA-
PKB (HA Akt)/cyo and Eyeless- Gal4; UAS-GSK-3/]/cyo females were crossed to UAS-
babo/ UAS-babo, UAS-BaboQD ( UAS BaboQ302D)! UAS-BaboQD and wlll8 (Control) 
males. Eyeless-Gal4,· UAS-PI3KDN (UAS-Dpll0° 954A)Icyo females were crossed to 
UAS-BaboQD and wlll8 (control) males. GMR-GAL4/cyo; UAS- BaboQ0 /TM3 flies were 
generated from the original line (UAS BaboQD) using standard genetic means. UAS-PJ3K 
(UAS-DpllO), UAS-PJ3KDN (UAS-dpll0°954A ), UAS-Dakt, UAS-dFOXO, UAS-mFOXO 
(murine FOXO), UAS-mFOXdA ( mFoxolr2.;A;s253A), UAS-sgg (UAS-sgg5xHisTag), UAS 
sggS9A and UAS-sggKD (UAS-sggK83 M) males were crossed to GMR-GAL4; wlll8 
(control) and GMR GAL4; UAS- BaboQD males. 
Driver lines Eyeless- Gal4 and Glass multiple reporter (GMR-Gal4) were obtained from 
the Bloomington stock center, along with UAS-sgg, UAS sggS9A and UAS-sggK0 . UAS-
Dakt is described in Staveley, eta!., ( 1998). UAS-dFOXO, UAS-mFOXO and UAS-
mFOXdA are described in Kramer et al., 2003. Eyeless-Ga/4,· UAS-HA-PKB (HA 
Akt)lcyo and Eyeless- Gal4; UAS-GSK-3/]/cyo were generated by Staveley, unpublished. 
UAS-PJ3KDN and UAS-PJ3Kwere generously provided by Dr. Sally Leevers (1996). 
UAS-dActivin-{3 dsRNA.HL , UAS-baboQD and UAS- babo were generously provided by Dr. 
Mike O'Connor (Brummel eta!., 1999). 
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Table 3: Drosophila and Mammalian Names 
Drosophila Homologue 
dActivin 
Baboon (Babo) 
DpllO, dPI3K 
dAkt 
dFOXO 
Shaggy 
36 
Mammalian Homologues 
Activin 
Type I Activin/TGF -~ 
Receptors (ALK) 
PI3K 
Akt 1, 2, 3 
FOXOI , 3, 4 
GSK-3a/~ 
Analysis of Adult Eyes 
Flies were selected via markers for the desired genotypes, and frozen at - 70°C in 
a 95 % ethanol bath to await further analysis. For scanning electron microscopy (SEM), 
two-day-old females were coated in gold and desiccated overnight a described by 
Kramer and Staveley (2003). Pictures were taken at 150x magnification using a SEM and 
a Hitachi camera. Negatives of the SEM pictures were scanned into Adobe Photoshop, 
and contrast/intensity/brightness was adjusted for each picture individually to obtain a 
clearer image. All pictures were cropped such that there was no change in relative 
magnification to facilitate comparison of eye size. All analyses were done on a minimum 
of three separate animals. 
Statistics 
All experiments were repeated in triplicate. For Drosophila experiments, a 
minimum of 6 flies was examined by SEM, and three images were captured. 
Calculations for the growth assays were done using Microsoft Excel spread heets and 
graphs were generated using GraphPad Prism 4. One way ANOV A analy s for growth 
assays were performed using GraphPad Prism. 
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Chapter 3: Results 
Chapter 3.1 Fibroblast Signalling 
To investigate the molecular signalling pathways of TGF-p, I wanted to describe 
Smad-independent pathways involved in cell cycle and growth regulation of fibroblasts. 
Given prior evidence ofTGF-~ signalling through Akt (Shin et al. , 2001) and this 
protein's well-characterized involvement in growth and cell cycle, an interaction with Akt 
pathway components was examined in fibroblast cells. I first wished to look at the 
activation ofPDK-1, a kinase responsible for the phosphorylation ofT-308, a 
phosphorylation site necessary for the activation of Akt (Figure 3A). A time course in 
AKR-2B cells demonstrates that there is an increase in PDK-1 erine 241 
phosphorylation by 60 minutes that continued through 180 minutes. Next, we wanted to 
examine the temporal effects ofTGF-P on Akt activation. We were unable to examine 
phosphorylation at the T-308 site, as the antibody was unfeasible in both TGF-~ and EGF 
positive control treated cells (data not shown). Akt protein was analyzed for changes in 
phosphorylation (P-Akt, Serine 4 73) by Western blotting. Varying times of stimulation 
by TGF-~ determined optimal timing for later experiments. In fibroblast cells (Figure 
3B), there is an increase in S-473 phosphorylation starting at 60 minutes and increasing 
through 180 minutes. This was replicated in triplicate in 3 fibroblast cell lines to ensure 
that the phenomenon examined was not specific to a particular cell line. As well, we 
wished to evaluate the interaction ofPI3K and the TGF-~ receptors in Akt 
phosphorylation in fibroblasts. The PI3K specific inhibitor, L Y29004, was used at a 
I Of-1-M concentration to minimize non-specific effects such as non-specific inhibition of 
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Time in mins. TGF-132 0 30 60 90 120 180 
A P-PDK-1 
Total PDK-1 
Time in mins. TGF-132 o 30 60 90 120 180 0 180 0 180 
B P-Akt 
Total Ak:t 
AKR-2B NIH-3T3 NRK-49F 
Figure 3: TGF-8 induced PDK-1 and Akt phosphorylation is increased in 
fibroblasts 
Fibroblast cells were sparsely plated and serum-depleted for 16 hours prior to stimulation 
with 1ng/ml TGF-132 for indicated time points. (A) PDK-1 phosphorylation is increased 
by TGF-13 treatment in AKR-2B cells. Temporal effects ofTGF-13 on PDK-1 were 
assayed for changes in phosphorylation at Serine 241 in AKR-2B cells. Total PDK-1 was 
then probed as a loading control. (B) TGF-13 activates Akt in fibroblast cells. Temporal 
effects ofTGF-13 on Akt activation were analyzed for changes in phosphorylation (P-Akt, 
S-473) by Western blotting. In fibroblast cells (AK.R-2, NIH-3T3 and NRK-49F), an 
increase was noted by 180 minutes. Total Akt was probed as a loading control and all 
experiments were repeated in triplicate. 
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Figure 4: TGFB induced Akt phosphorylation is dependent on both receptors and 
PI3K. 
Cells were plated at low density and serum-depleted for 16 hours prior to stimulation. (A) 
Akt phosphorylation is dependent on PI3K activity. AKR-2B cells were stimulated with 
or without 2ng/ml TGF -(32 for 180 minutes in the presence/absence of 1 Of,A.M L Y29004 or 
1 f,A.M Akt IV inhibitors. Phosphorylated Akt (S-473) was then assayed by Western 
Blotting, with total Akt probed as a loading control. (B) Akt phosphorylation requires 
activity of both TGF-(3 receptors. Stable chimeric receptor lines of wild type (AHM-4), 
the TGF-(3 Type I (A618) and II (A706) kinase dead receptors were stimulated for 120 
minutes with 5ng/ml TGF-(32 or GM-CSF as indicated. Akt phosphorylation was then 
assayed by Western Blotting, with total Akt being probed as a loading control. All 
experiments were repeated in triplicate. 
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inhibitors reduced S-473 phosphorylation of Akt in response to TGF-~ stimulation 
(Figure 4A), indicating that TGF-~ actions on Akt is through activation of PI3K. 
The ability of the TGF-~ ligand to signal requires two receptors, the TGF~Rl and 
TGF~RII . To study the role of the receptors in the activation of Akt, we used a chimeric 
TGF~ receptor model system as described by Anders and Leof (Anders eta!., 1996). This 
allows for the creation of receptors that only respond to GM-CSF, while leaving the 
native TGF~ receptor system intact and responsive to TGF~ as an excellent internal 
control. To show if the kinase activity ofthe receptors was essential for Akt 
phosphorylation we utilized 3 stable clonal lines: one that expresses both wild type 
receptors (AHM-4), one that expresses a kinase dead Type I (A 706) and one that 
expresses a kinase dead Type II (A618). As expected, the signal generated by GM-CSF, 
relative to TGF~, was greatly increased, likely due to overexpression of chimeric 
receptors (Figure 4B). Both of the kinase dead lines did not display an increase in 
phospho-Akt in response to GM-CSF, indicating that the kinase activity of both type r 
and II TGF~ receptors is essential for Serine 4 73 Akt phosphorylation. The normal 
endogenous response to TGF~ was not impaired in these cell lines, indicating there is not 
impairment in the ability of TGF~ receptors to activate Akt in these cell lines. 
Since we were especially interested in the growth promoting and cell cycle effects 
ofTGF-~, we picked GSK-3~ for further analysis. GSK-3~ has been previously shown to 
be involved in both growth and cell cycle (Doble eta/. , 2003). In fibroblast cells (AKR-
2B, NRK-49F and NIH-3T3), there is an increase in serine 9 phosphorylation by 90 
minutes increasing through 180 minutes (Figure SA, B). These results correlate well with 
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the timing of Akt activation, as Akt is responsible for Serine 9 phosphorylation of GSK-
3~, inactivating the protein kinase activity. This action should potentially lead to a 
decrease in phosphorylation of GSK-3~ targets. This Serine 9 phosphorylation event of 
GSK-3~ was also dependent on both PI3K and Akt activity as both L Y294002 and Akt 
inhibitor IV, blocked TGF-~ mediated increases in GSK-3~ phosphorylation (Figure 5C). 
This indicates that GSK-3~ phosphorylation by TGF-~ stimulation is dependent on both 
PI3K and Akt activity. 
It has been previously shown that GSK-3~ can phosphorylate Cyclin 01 at Thr 286 
(Diehl et. al. , 1998) resulting in cytoplasmic relocalization, disruption of binding to 
CDKs and degradation. TGF-~ can regulate Gl /S progression and regulate Cyclins via an 
unknown mechanism (Laiho et al. , 1990). We hypothesize that in response to TGF~ 
stimulation, GSK-3~ is inactivated in fibroblasts altering Cyclin D 1 activity. Cyclin D 1 
phosphorylation was examined by Western blotting and found to decrease by 180 
minutes following TGF-~ addition (Figure 6A). This time point coincides with increased 
in P-GSK-3~ and therefore inactive GSK-3~. Additionally, nuclear extracts from TGF-~ 
treated cells revealed Cyclin D1 localizes to the nucleus, consistent with the known 
activity of unphosphorylated Cyclin D 1 (Figure 6B). In addition to the cellular location of 
cyclin D 1, binding to CDK-4 is necessary for proper functionality. As shown in Figure 
6C, stimulation with TGF-~ alone cause increased complex formation, and L Y20004 
blocked this event. This suggests that TGF-~ is able to directly regulate the Cyclin 
Dl/CDK complex formation in a PI3K dependent manner. 
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Time in mins. TGF-P2 
A P-GSK-313 
Total GSK-313 
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B P-GSK-313 
Total GSK-313 
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Figure 5: GSK-36 phosphorylation is increased and dependent on PI3K and Akt. 
Fibroblast cells were plated at low density, serum depleted for 16 hours, and stimulated 
with TGF-132 for indicated time points. TGF-13 inactivates GSK-313 in Fibroblast cells. 
(A) Temporal effects ofTGF-13 on GSK-313 inactivation were analyzed for changes in 
phosphorylation after 1 ng/ml TGF-132 stimulation (P-GSK-313, S-9) by Western blotting. 
Total GSK-313 was probed as a loading control (B) In other fibroblast cells (NIH-3T3 and 
NRK-49F), there was an increase by 180 minutes. (C) Phosphorylation of GSK-313 is 
dependent on both PI3K and Akt. AKR-2B cells were stimulated with or without 2ng/ml 
TGF-132 for 180 minutes in the presence/absence of 10!-1-M L Y29004 and 1 f!M Akt IV 
inhibitors. Phosphorylated GSK-313 (S9) was then assayed by Western Blotting, with total 
GSK-313 probed as a loading control. All experiments were done in triplicate. 
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Figure 6: TGF -8 induces decreased phosphorylation and nuclear localization of 
Cyclin Dl. 
Fibroblast cells were seeded at low density, serum depleted for 16 hours, and stimulated 
with TGF-P2 for indicated time points. (A) Temporal effects of TGF-~ on Cyclin D1 
phosphorylation were analyzed for changes by Western blotting, with total Cyclin D1 
being probed as a loading control. There is a decrease in Cyclin Dl phosphorylation at 
the GSK phosphorylation site (T-286) by 90 minutes. (B) Nuclear extracts were prepared 
and assayed for Cyclin D1 showing localization to the nucleus with TGF-~ treatment. 
(C) Correlating with this localization event, increased complex formation of Cyclin D 1 
with CDK-4 was observed and was shown to be PBK dependent. 
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Having possibly defined a TGF-[3/Akt pathway signaling mechanisms of 
fibroblasts, we wished to determine the biological effects controlled by this novel 
pathway. To look at the role of Akt activation in regulation cytoskeleton and cellular 
morphology, we undertook a morphological transformation assay. Fibroblast cells that 
are stimulated with TGF-[3 will take on an elongated, myofibroblast appearance with 
actin stress fibers forming along the long axis of cells when compared to untreated 
controls (Figure 7, panel B and A respectively). In addition to the standard brightfield 
photomicrographs, cells were stained with FITC labelled phalloidin, which detects actin 
filaments (filamentous actin). When Akt IV inhibitor is added to the media with TGF-[3, 
the elongated cell morphology was prevented (Figure 7 panel C and D), however there is 
still evidence of actin stress fiber formation. 
As well as causing morphological transformation, TGF-[3 can induce growth in 
fibroblasts. To study the role Akt plays in TGF-f3 mediated growth, we utilized a 3H-
thymidine assay to measure DNA synthesis. This is an indirect measure of growth, as it is 
assumed that cells undergoing DNA synthesis progress to mitosis to give increased cell 
nwnber. We found that inhibition of Akt blocked TGF-f3 mediated growth (Figure 8). A 
significant difference was found between TGF-[3 and Akt/TGF-[3 treated conditions 
(p<O.OO 1, One way ANOV A, corrected for multiple comparisons using Bonferroni t-
test), with no difference being found between the untreated controls and inhibitor alone. 
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With TGF-~2 
Control 
1 J.LM Akt IV 
Figure 7: Inhibition of Akt attenuates TGF-8 induced morphological 
transformation. 
AKR-2B cells were grown to confluence then placed in serum free media for 48h and 
Akt inhibitor was added to cells with or without 5 ng/ml TGF-f3. The cells treated with 
inhibitor alone were similar to control untreated cells. In the upper right panel (B), the 
morphological transformation event can be seen as elongated cells when compared to the 
control (A). When both the inhibitor and TGF-f3 are present, there is little transformed 
phenotype (D). This suggests that Akt plays a role in TGF-f3 induced morphological 
transformation. 
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Figure 8: Inhibition of Akt reduces TGF-8 induced growth. 
NIH-3T3 cells were plated, allowed to attach 24 hours, and then stimulated with 5 ng/rnl 
TGF-~2 with or without Akt IV inhibitor and 3H-thymidine incorporation measured. 
The cells treated with inhibitor alone were similar to control untreated cells. When both 
the inhibitor and TGF-~ are present, there was no increase in growth, as with TGF-~ 
alone. This suggests that Akt is involved in TGF-~ induced mitogenesis of fibroblasts. A 
star indicates the statistically significant treatment. 
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Chapter 3.2 Epithelial Signalling 
Since fibroblasts are growth stimulated by TGF-~ and this response requires Akt, 
we wished to examine TGF-~ signalling in epithelial cells. TGF-~ has known differential 
effects on growth/cell cycle between fibroblasts and epithelial cells, causing a G liS block 
and decreased growth in epithelial cells and increased G liS progression and growth in 
fibroblast (Laiho et al. , 1990). Since the Smad signalling pathway is the same in both cell 
types (Massague, 2000), and Pak2 is active only in fibroblasts we wished to extend these 
findings to Akt signalling (Wilkes et al. , 2003). 
We examined PDK-1 phosphorylation (Figure 9A) and found that this event is 
decreased by 90 minutes in the NMuMG cell line. When Akt phosphorylation is 
examined in response to TGF-~ (Figure 9 B, C) in epithelial cells, there is a decrease by 
90 minutes, with a loss of phosphorylation seen by 120 minutes. Again, we examined two 
cell lines (MvlLu and NMuMG) to ensure this is not a cell line specific event. Jn the 
epithelial lines, a slight difference is noted that the NMuMG line seems to respond 
' faster' than the MvlLu line (Figure 9 B, C). However, as the MvlLu are grown in their 
complete media, this difference in signaling could be due to other growth factors 
increasing the background of Akt phosphorylation. 
We also wished to establish if there was any potential differences in GSK-3~ 
phosphorylation with TGF-~ stimulation. Figure 10 shows that phosphorylation ofGSK-
3~ at S-9 is decreased on a similar time frame to Akt. Again this was replicated in two 
different epithelial cell lines to ensure this is not a cell line specific event. This suggests 
that as Akt becomes dephosphorylated (and therefore inactive) it is unable to 
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Time in mins. TGF-f32 0 30 60 90 120 180 
A P-PDK-1 
Total PDK-1 
Time in mins. TGF-f32 0 30 60 90 120 180 
P-Akt B 
Total Aktl.._ -----J~ 
Time in mins. TGF-f32 0 30 60 90 120 180 
c 
Fif!llre 9: TGF-8 decreases Akt and PDK-1 phosphorylation in epithelial cells 
Epithelial cells were plated, allowed to attach for 24 hours, growth factor depleted for 16 
hours and stimulated for the indicated time points with 1 ng/ml TGF-(32. 
(A) PDK-1 phosphorylation is decreased by TGF-(3 treatment in NuMG cells. Temporal 
effects ofTGF-(3 on PDK-1 (Serine 241) phosphorylation were assayed for changes in 
phosphorylation in NuMG cells, with total PDK-1 being blotted as a loading control. 
There was a decrease in phosphorylation at 180 minutes. (B) TGF-(3 decreases Akt 
phosphorylation in NuMG cells. Phosphorylation of Akt (S-473) was assayed for 
changes, with total Akt being blotted for a loading control. TGF -(3 caused a decrease by 
120 minutes, with little phosphorylation left at 180 minutes. (C) Mvl Lu cells also display 
decreases phosphorylation of Akt with TGF-(3 stimulation over a similar time frame. 
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Time in mins. TGF-~2 0 30 60 90 120 180 
A P-GSK-3~ 
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Time in mins. TGF-~2 0 30 60 90 120 180 
B P-GSK-3~ 
Figure 10: GSK-38 phosphorylation is decreased in epithelial cells in response to 
TGF -8 stimulation. 
(A) TGF-~ decreases phosphorylation of GSK-3~ in NuMG cells. Epithelial cells were 
seeded, allowed to attach for 24 hours, growth factor depleted in 10% FCS/DMEM for 16 
hours and stimulated for the indicated time points with 1 ng/ml TGF-~2. Between 60 and 
90 minutes there is a decrease in phosphorylation of GSK-3~ (Serine 9), with no 
detectable phosphorylation by 180 minutes. (B) MvLu cells also display decreases 
phosphorylation of GSK-3~ with TGF-~ stimulation over a similar time frame. 
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phosphorylate GSK-3~ at Serine 9. 
Since TGF-~ causes a G 1/S block in epithelial cells, we wished to examine the 
effects on Cyclin D 1 since this pathway could explain how TGF-~ mediates this action. 
Surprisingly, we found no increase in phosphorylation ofCyclin D1 as would be 
expected if more active GSK-3~ is present in the cell (Figure 11A). However, we noted a 
decrease in the total Cyclin D 1. Since phosphorylation of Cyclin D 1 causes rapid 
degradation of the protein, perhaps this is why we did not detect an increase. We also 
examined the effects of TGF-~ on Cyclin D 1 localization, and found that the total protein 
levels were decreased in both cytoplasmic and nuclear fractions (Figure 11 B). This is 
consistent with the idea that TGF-~ is causing the breakdown of Cyclin D I. When we 
examined complex formation, we found that TGF-~ decreases the amount of CDK-4 that 
is found in complex with Cyclin D 1 (Figure 11 C). All together, this data suggests that 
TGF-~ can: 1) decrease the amount ofCyclin D1 in the cell and 2) inhibit the function of 
Cyclin Dl/CDK-4 complexes. Both of these events have been shown to low the 
progression through G liS. 
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Figure 11: TGF-8 decreases protein levels ofCyclin Dl and association with CDK-4. 
Epithelial cells (NuMG) were plated, allowed to attach for 24 hours, growth factor 
depleted for 16 hours and stimulated for the indicated time points with 1 or 2ng/ml TGF-
~2. (A) Temporal effects ofTGF-~ on Cyclin Dl phosphorylation were analyzed by 
Western blotting. There is no change in Cyclin Dl phosphorylation at the GSK 
phosphorylation site (T-286) by 120 minutes, with total protein levels being 
corresponding decreased (B) Nuclear extracts were prepared and assayed for Cyclin D 1 
showing decreases in protein levels in both the cytoplasmic and nuclear fractions with 
TGF-~ treatment. (C) Correlating with this loss of total Cyclin D1 , decreased complex 
formation ofCyclin D1 with CDK-4 was observed. 
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Chapter 3.3 Drosophila Model ofTGF-~/Akt signaling 
In addition to our in vitro signaling model in cell culture, we wished to determine 
if there is a genetic interaction between TGF-~ signalling and the Akt pathway in 
Drosophila. To accomplish this aim, we used the UAS/Gal4 ectopic sy tern of gene 
expression (Brand and Permmion, 2003) to overexpress components ofTGF-~ and Akt 
signalling in the developing eye. This system was developed from yea t, utilizing the 
Gal4 transcription factor that binds to a specific upstream activator sequence (UAS). One 
line is the 'driver' line that contains a promoter upstream of GAL4. The econd line 
contains the UA upstream of a gene product. When the lines are crossed together, the 
Ga14 binds to the UAS sequence to express the gene product in a temporal and spatial 
manner. This system has the advantage that lethal mutations can be expressed in a tissue 
specific manner, thereby bypassing early developmental roles of the protein that may 
cause lethality. Also, UAS sequences are not present in the Drosophila genome, ensuring 
there is no non-specific expression of the gene. 
In our study we utilized two driver lines: eyeless-Ga/4 and GMR-Gal-1. Eyeless-
Ga/4 is expressed early in the eye primordia, before photoreceptor differentiation and 
continues expression until the completion of eye development. It is commonly used to 
determine if a gene product is necessary for patterning decisions in the eye. GMR-Gal-1 
specifically activates gene expression within and posterior to the morphogenetic furrow 
during late eye development allowing the study of cellular growth decisions distinct from 
early eye patterning. The driver lines were also crossed to w 1118 as a control. As high 
levels of the GAL4 protein have been shown to cause apoptosis and developmental 
53 
defects in the developing eye (Kramer and Staveley , 2003), this control is necessary for 
comparison to ensure no off-target effects. 
For our frrst set of experiments, we wished to examine the TGF-~ Activin!fGF-
~RI homologue in flies, Baboon and its ligand dActivin. Expression of the normal 
Baboon receptor under both the control of the eyeless and gmr promoter has little effect 
on growth of the eye as determined by visual comparison (Figure 12 B and E 
respectively, compared to 12 A and D), with perhaps slightly increased bristle size being 
the only phenotype seen. Since the normal Baboon receptor is highly overexpressed 
compared to levels of both the endogenous ligand ( dActivin) and its type II receptor 
(Punt), it is not surprising that little effect was seen with this construct. Also, Brummel et 
al. , 1999 did not see any effect on wing size when overexpressing this construct. In 
addition, we misexpressed a dominant negative construct of dActivin and saw little effect 
on the size or patterning of the eye (Figure 12B compared to the control 12A). When the 
Baboon receptor was expressed in conjunction with Akt, a small increase in the total eye 
size may be present (Figure 12 F and G) . Expression of the wt Baboon receptor in 
conjunction with human GSK-3~ had no effect (Figure 12 Hand I). In all , overexpression 
of the wild type receptor or inhibiting the wild type ligand had no discernable effect on eye 
development. 
We also misexpressed an activated form of the Baboon receptor (Baboon° 0 ). 
This mutation is in the glycine-serine rich (GS) domain of the receptor. The GS domain is 
where the Type II TGF-~ receptors phosphorylated the Type I receptors to activate kinase 
activity, and therefore downstream signalling. Baboon° 0 contains an amino acid change 
at position 302 from glutamine to aspartic acid, to produce a constitutively active 
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Figure 12: Overexpression of normal TGF-6 components reveals no phenotype. 
Overexpression of either dActivin (B) or Baboon (C) had little effect on eye development 
with GMR-Gal4 compared to GMR-Gal4 flies alone (A). Expression of Baboon with 
eyeless driver (E) resulted in slightly longer bristles when compared to wildtype (D). 
When coexpressed with GSK (G) had little effect when compared to GSK (F) alone. 
When coexpressed with Akt (I) a slightly larger eye is noted, when compared to Akt 
alone (H) or eyeless Gal4 alone (D). 
(A) GMR-Ga/4/+ (B) GMR-Ga/4/+; UAS-dActivin/+ (C) GMR-Ga/4/+; UAS-babol+ 
(D) eyeless-Ga/4/+ (E) eyeless-Ga/4/+; UAS-Babo/+ (F) eyeless-Ga/4,· UAS-Akt (G) 
UAS-babo/eyeless-Ga/4; UAS-Akt (H) eyeless-Ga/4,· UAS-wtGSK-3fJ/+ (I) UAS-
babo/eyeless-Ga/4; UAS-wtGSK-3fJ 
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receptor, presumably through an increase in kinase activity of the receptor (Brummel et 
a!., 1999). When we expressed this form of the receptor with the eyeless promoter, we 
saw severe outgrowth from the eye (Figure 13 A, E). When coexpres ed with wildtype 
Akt, we saw a synergic effect, which would be expected if the normal function of this 
receptor were to activate Akt (Figure 13 B, F). Loss of dPI3 K in Drosophila has 
previously been implicated in the regulation of cell size and number (Leevers et. al, 
1996). Expression of a dominant negative PI3K (PI3K0 N ) construct, which partially 
blocks endogenous PI3K function (Leevers eta!. , 1996), caused are cue of the 
Baboon° 0 overgrowth phenotype (Figure 13 C, G). This result indicate that PI3K is 
genetically downstream of Baboon, as it was able to rescue the phenotype. As well, 
expression of wtGSK3~ caused a partial rescue of the Baboon° 0 phenotype (Figure 13 D, 
H). When the Baboon° 0 construct was expressed with the GMR promoter, as less severe 
phenotype was seen resulting in increased organ size and bristle size, with no outgrowth 
of ommatidia seen from the eye (Figure 14 A, E). Coexpres ion of PI3K0 also rescued 
the Baboon°0 phenotype, providing additional confirmation of the results noted above 
(Figure 14 B,F). Expression of either wtPI3K or Akt with Baboon° 0 caused a synergic 
effect on growth of the eye, with many more bristle being noted in the eye (Figure 14 C, 
D, G, H). 
We also wanted to extend our understanding of the components of this pathway to 
establish the roles of dFOXO and Shaggy in modulating the Baboon° 0 phenotype. The 
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Figure 13: Activated form of TGF -8 receptor interacts with PI3K signalling 
components in Drosophila. 
Using the UAS/Gal4 system of ectopic gene expression in Drosophila, we expressed the 
activated form of the Baboon receptor (BaboQ0) with PBK signalling components (Akt, 
PBK-DN and GSK-3~) under the control of the eyeless promoter. Eyeless-Gal4/UAS-
BaboQ0 reveals a phenotype that is grossly overgrown. Expressing dAkt in conjunction 
with BaboQD causes increased overgrowth relative to activated Baboon alone, whereas 
expression of a PI3K0N mediates Baboon overgrowth. Expression of GSK also controls 
overgrowth of ommatidia, however the rounder eye phenotype of the Babo QD remains. 
All flies are representative of phenotypes seen, and at least 3 separate animals were 
examined by SEM. (A) eyeless-Ga/4/+ (B) eyeless-Ga/4,· UAS-PJJJ<?N (C) eyeless-
Ga/4; UAS-Akt (D) eyeless-Ga/4,· UAS-wtGSK3{3 (E) eyeless-Ga/4/+; UAS-BaboQ0/+ (F) 
UAS-BaboQ0 /eyeless-Gal4; UAS-PJJJ<?N (G) UAS-BaboQ0 /eyeless-Gal4; UAS-Akt (H) 
UAS-BaboQ0/eyeless-Gal4; UAS-wtGSK3{3 
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Figure 14: TGF-B Type I receptor interacts with PI3K signalling components in 
Drosophila. 
Using the UAS/Gal4 system of ectopic gene expression in Drosophila, we expressed 
UAS-Babo00 with PI3K signalling components (PI3KDN, wt-PBK and dAkt) under the 
control of the GMR promoter. GMR/ Activated Baboon reveals a phenotype that is 
overgrown. Expressing wt-PBK or Akt in conjunction with Baboon causes increased 
overgrowth relative to activated Baboon alone, whereas expression of a PBKDN reduces 
Baboon overgrowth indicating a genetic link between PBK and TGF-(3 receptor 
signalling. All flies are representative of phenotypes seen, with at least 3 sejarate animals 
being examined for SEM. (A) GMR-GAL4/+ (B) GMR-Ga/4; UAS-P!3K? (C) GMR-
Ga/4; UAS-dPI3K (D) GMR-Ga/4; UAS-dAkt (E) GMR-Ga/4/ UAS-BaboQD (F) GMR-
Ga/4; UAS-BaboQ0 / UAS-PI3K?N (G) GMR-Ga/4; UAS-BaboQ0/ UAS-dPI3K (H) GMR-
Ga/4; UAS-BaboQ0 / UAS-dAKT 
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phenotype of dFOXO when expressed in the eye is the overall organ size is smaller with 
missing ommatidia and bristles. As describe by Kramer eta!. (2003) the phenotype of 
overexpression of mFOXO is similar due to the high level of conservation between 
mouse Drosophila genes. Misexpression of the Baboon° 0 transgene with dFOXO or 
mFOXO caused a rescue of the FOXO phenotype (Figure 15 B,C,F,G) when compared to 
controls GMR-Gal4 (A) and GMR-Gal4; Babo00 (E), with a rescue of eye size, cell 
number and bristles as observed by visual observation. This result arises from two 
possibilities: 1) Baboon rescues dFOXO through an Akt dependent mechanism or 2) 
Baboon simply increases growth of ommatidia through a FOXO-independent mechani m. 
To address this, we utilized a form of FOXO (mFOXOAA) that has been previously been 
shown to be unresponsive to Akt as two of its Akt responsive phosphorylation sites have 
been mutated to alanine (Kramer eta/. , 2003) which causes the protein to be 'always on' . 
mFOXOAA causes a much more severe phenotype than expression of either dFOXO or 
mFOXO (Figure 15 H compared to B, D). Misexpression of Baboon° 0 with mFOXOAA 
(Figure D,H) was unable to rescue the effects ofFOXO. This strongly indicates that the 
rescue of FOXO by Babe is dependent on the Akt phosphorylation sites, placing Babo 
genetically upstream of both dAkt and dFOXO. Another downstream target of Akt is 
G K-3j3. Drosophila contains only one G K homologue, termed Shaggy. haggy in 
Drosophila is best known for its role in Wingless signaling (Parks eta/., 1998). However, 
other roles for this kinase have been described. Mutants in the Shaggy locus (later 
discovered to be the Drosophila GSK homologue) cause extra bristle formation (Simpson 
and Cartenet 1990) in pro-neural clusters in the thorax. Therefore, Shaggy is thought to 
be essential for selecting the single cell in the 
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Figure 15: Activated form of TGF -8 I receptor interacts with FOXO in Drosophila 
Misexpression using the UAS/Gal4 system of d.FOXO or mFOXO with the BaboQ0 
transgene caused a rescue of the FOXO phenotype. Misexpression of BaboQD with 
mFOXOAA did not rescue the phenotype (Figure D,H), with no increases in cell number 
or bristles. All flies were representative of phenotypes seen, and SEM analysis was done 
on at least three separate animals. (A) GMR-GAL4/+ (B) GMR-Ga/4; UAS-dFOXO (C) 
GMR-Ga/4; UAS-mFOXO (D) GMR-Ga/4; UAS-mFOXOU (E) GMR-Ga/4/UAS-
BaboQD (F) GMR-Ga/4;UAS-BaboQD; UAS-dFOXO (G) GMR-Ga/4 ; UAS-BaboQD/ UAS-
mFOXO (H) GMR-Ga/4; UAS-BaboQD; UAS-mFOXOU 
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Figure 16: TGF -8 Type I receptor interacts with Shaggy signalling components. 
We expressed the activated form of the Babo with the Drosophila homologue of GSK, 
Shaggy (Sgg) under the control of the GMR promoter. As shown in Figure 14 the 
GMR/ Activated Baboon phenotype is overgrown. Expressing wt-Sgg, or Sgg that cannot 
be inactivated by phosphorylation (SggS9A), in conjunction with Baboon partially 
reduces overgrowth. Expression of an Sgg kinase dead reveals much longer and 
numerous bristles, and coexpression with Baboon worsens the phenotype. This result 
shows that Babo can signal through GSK/Shaggy in Drosophila. Additionally, the similar 
and additive phenotypes of Babo and SggDead suggest Babo is one of the signalling 
components for increased bristle size. (A) GMR-GAL4/+ (B) GMR-Ga/4; UAS-s~fb (C) 
GMR-Ga/4; UAS-sggs9A (D) GMR-Ga/4; UAS-sgg-'ead (E) GMR-Ga/4/ UAS-Babo (F) 
GMR-Gal4;UAS-BaboQD; UAS-sgg (G) GMR-Ga/4 ; UAS-BaboQDIUAS-sgf!9A (H) GMR-
Ga/4; UAS-BaboQD I UAS-sggdead 
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proneural cluster that will differentiate into bristles. Overexpression of a wt-Sgg or a 
constitutively active Sgg (Sggs9A) in the differentiating sensory structure causes a loss of 
a bristle subtype in the wing and a loss of bristles on the thorax (Bourouis, 2002). No 
effect of a kinase-dead version of Sgg was observed under these conditions, other than it 
was unable to repress Wingless signaling. 
Expression of Sgg constructs in the eye has not been carefully examined. Given 
the whole animal work, and the mutant phenotype, we expected to see a bristle 
phenotype. Expression of Sgg or Sggs9A under the control of Gal4 had little effect on the 
eye with perhaps the eye being a little smaller (Figure 16 B, C) whereas expression of 
Sggdead revealed longer and numerous bristles when compared to both wildtype (Figure 
16A) and the other Sgg constructs. When Sgg is coexpressed with Babo00, suppression 
of the overgrowth phenotype is seen (Figure 16 B, F). However, coexpression of 
Shaggys9A and Babo00 showed an improved rescue over wt-Sgg (Figure 16 C, G 
compared to B, F). Expression of SggDead and Babo0 0 had a synergic effect on bristle 
growth, with a hairy eye phenotype being noted with lots of bristles. Sggdead also 
suppressed the Babo00 overgrowth phenotype. This suggests Baboon also normally 
inactivates Shaggy during eye development to promote growth of ommatidia and is 
involved in bristle growth/ differentiation. 
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Chapter 4: Discussion 
The area of cellular growth and its relationship to cell cycle is a highly researched 
area, with relevance to many human disorders such as cancer. Various growth factor 
pathways have been shown to be involved. One of note is TGF-~ signaling; in particular 
because TGF-~ causes distinct responses in different cell types, suggesting this important 
cytokine has different signalling pathways. The classical Smad signalling pathway is 
essentially the same in all cell types, leading to the hypothesis that different cell types 
have additional signalling pathways. Indeed, many previous studies have shown that 
TGF-~ can act in a Smad-independent manner to activate signalling in mesenchymal 
lineages. TGF-~ can activate ERK signalling kinase, along with Rho-like GTPases, Rho 
A, Rae] and cdc24 (Edlund, 2002). When activated by TGF-~, each contributes to 
cytoskeletal reorganization. Recently, TGF-~ has been shown to specifically activate 
PAK2 in fibroblast cell lines but not epithelial cells in a pathway that requires cdc42 
(Wilkes et al. , 2003). This event was shown to be independent of Smad signaling and 
dependent on TGF-~ receptors. Inhibition ofPAK2 leads to defects in TGF-~ mediated 
growth and MT in these fibroblast cell lines. A more recent report (Wilkes et al. , 2005) 
has linked TGF-~ receptors to both PI3K and Akt in a linear pathway, however, nothing 
was reported on signalling downstream of Akt. This report also determined that in 
epithelial cells, PI3K/Akt pathways are not activated. A role for PI3K has also been 
described in epithelial to mesynchemal transition (EMT) of epithelial cultures 
downstream of TGF-~ through activation of the PI3K target, Akt (Bakin eta!. , 2000; 
Shin et al. , 2001 ). Increased activation of PI3K has been shown in fibroblastic cell 
lineages, as well as epithelial cultures (Kim et al. , 2002). However, especially with 
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epithelial cultures, several groups fai l to show 'activation' of Akt when stimulated with 
TGF-13 (Conery et al., 2004; Seoane et al., 2004; Wilkes et al. , 2005). Since the major 
question appears to be how TGF-13 causes growth stimulation versus growth inhibition, 
the study ofPI3K/Akt signalling may be one method by which different cell types 
interpret TGF-13 signalling. This study provides convincing evidence that TGF-13 is 
signalling via PI3K/Akt in both mammalian cell culture and Drosophila melanogaster in 
a cell type specific manner. 
4.2 Fibroblast Signalling 
Our results indicate that TGF-13 activates Akt by phosphorylation at Serine 473 , 
and this event is dependent on a PI3K and other upstream kinases in fibroblasts. Another 
upstream kinase, PDKl is also required for Akt phosphorylation at threonine 308. Akt 
activation, through phosphorylation, also requires intact TGF-13 receptors in order for 
signal propagation. These data agrees with Wilkes eta!. , (2005) who found a simi lar 
trend with respect to Akt phosphorylation at Serine 473 and Threonine 308 increasing 
until 120 minutes when fibroblast cells were stimulated by TGF-131. This group found 
that TGF-13 was able to induce PI3K activity in fibroblast lines starting after 120 minutes 
of stimulation and L Y29002 (a PI3K inhibitor) abolished the activity. Akt 
phosphorylation by TGF-13 was also abolished by L Y29002 addition and use of a DN-
PDK-1. 
Wilkes eta!., (2005) also reported that Akt phosphorylation in fibroblast cells is: 
1) a SMAD-independent event and 2) through the use of inhibitors of either transcription 
or translation that TGF-13 mediated phosphorylation of Akt is independent of these 
processes . . This suggests that phosphorylation of Akt by TGF-13 is a direct event, not a 
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result of SMAD-mediated transcription. Our data characterized further downstream 
targets of Akt, such as GSK-3P in fibroblasts. I see increased phosphorylation ofGSK-3P 
over time in fibroblasts, and this event is dependent on PI3K and Akt. This data suggests 
that TGF-P has the ability to directly inactivate GSK-3p, through S9 phosphorylation via 
a direct linear pathway. Given that inactivating Cyclin D1 along with other targets 
involves GSK-3P in inhibiting the cell cycle, inactivation of the GSK-3P kinase activity 
should have a direct effect of increasing progression through cell cycle. This inactivation 
of GSK-3P should also increase growth as increased progression of cell cycle is directly 
linked to cellular growth. In this study I show TGF-P stimulation results in less Cyclin 
Dl phosphorylation, previously been shown to be GSK-3P dependent (Diehl et al., 1998) 
and increased nuclear localization of Cyclin D 1 and complex formation with CDK-4. All 
of these events have been correlated to increased G liS progression in various cell lines 
including NIH-3T3 (Ewen et al., 1993). As well, our data shows that Akt inhibition leads 
to decreased growth in NIH-3T3 fibroblast cells. This result consequently provides some 
evidence that TGF-P can control the cell cycle directly through a signalling cascade that 
does not depend on Smad signalling. Other groups have reported PI3K pathways acting 
on cell cycle by interactions with Smads (Seaone et al. , 2004). The current theory is that 
different Smad binding partners associating with the promoters of genes cause cell 
specific differences, and TGF-P does not signal to other pathways directly from the 
receptors. However, our data, in addition to that published by Dr. Leafs group (Wilkes et 
al., 2005 ; Wilkes and Leaf, 2006) suggests that there are other pathways directly 
involved in TGF-P signalling. To my knowledge, this is also the first report of TGF-P 
having a direct effect at the protein level on regulation of cell cycle components. 
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Use of our Akt IV inhibitor also prevents TGF-(3 mediated morphological 
transformation and growth of fibroblasts. Other targets of the TGF-(3 receptor complex 
uch as PI3K and PAK-2 have also been shown to be involved in the MT and growth of 
fibroblasts (Wilkes et al. , 2003 ; Wilkes eta/. , 2005). Akt has previously been shown to 
affect growth and cell cycle in different contexts using many targets. In breast cancer 
tumours, Akt can phosphorylate p27ktpi to promote cytosolic localization (Liang et al. , 
2002) thereby leading to increased G 1 progression. Negative regulation of FOXO by Akt 
results in decreased transcription of Cyclin D 1 ( chmidt et a/. , 2002) and enhanced 
transcription of p27kipi. Akt also negatively regulates GSK-3(3, causing decreased 
phosphorylation of Cyclin D1 , resulting in nuclear localization and higher protein levels 
(Diehl et a/. , 1998). Overexpression of Akt in both mice (Shioi et a/. , 2002) and 
Drosophila (Yerdu et al. , 1999) results in larger total organ size, with increases in cell 
size observed. Knockout mice in Akt 1/2 and Drosophila akt mutants both display severe 
reduction in body size (Peng et al. , 2003 ; Staveley eta!. , 1998). All these reports 
illustrate the critical role of Akt in G 1/S cell cycle progression and the overall growth of 
cells. In light of the above data, TGF-(3 can activate Akt, which then inactivates GSK-3(3 
leading to increased levels of Cyclin 01 should cause increased G liS progression and 
increased cellular growth. My data also illustrates that Akt is probably necessary for 
TGF-(3 mediated growth in fibroblasts (Figures 6 and 8). 
Overall , in fibroblasts , I show that TGF-(3 stimulates Akt activation. This leads to 
GSK-3(3 inactivation and a decrease in Cyclin Dl phosphorylation coupled to increased 
protein levels and nuclear localization. These events are correlated with increased 
progression into S phase, leading to increased rates of cell division. Indeed, blocking Akt 
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activation prevents TGF-~ growth stimulation of fibroblasts, GSK inactivation and 
Cyclin D 1 /CDK4 complex formation, suggesting that the Akt signalling is needed for this 
process. 
4.3 Epithelial Signalling 
As well as characterizing a fibroblast-signalling pathway, I wished to determine if 
this PI3K/Akt signalling pathway could differentiate fibroblasts from epithelial cells. A 
role for PBK has also been described in EMT of epithelial cultures downstream of TGF-
~ and in preventing apoptosis of epithelial cultures through activation of the PI3K target, 
Akt (Bakin et al. , 2000; Ju et al. , 2005). Increased activation of PI3K ha been shown in 
mesenchymal cell lineages as well as epithelial cultures (Kim eta/. , 2002; Shin eta/., 
2001). However, with epithelial cultures, several groups failed to see "activation" of Akt 
when stimulated with TGF-~ (Seaone et al. , 2004; Wilkes eta!., 2005). pithelial cells, 
in contrast to fibroblasts , are growth-inhibited by TGF-~ (Laiho et al., 1990). Therefore, I 
expected this signalling pathway not to be activated in epithelial cells, similar to the 
results obtained by Wilkes et al. (2005). Surprisingly, I found that TGF-~ caused a 
decrease in both Akt phosphorylation and that of the upstream kinase, PDK-1. Decreases 
in the phosphorylation of Akt have been hown to correlate with loss of kinase activity 
(Brazil el al. , 2001). In contrast to fibroblasts , GSK-3~ phosphorylation was likewise 
decreased in response to TGF-~, which corresponds to an increase in GSK-3~ activity 
(Cross eta!. , 1995). Increases in GSK-3~ activity should lead to increased 
phosphorylation of its downstream targets, including Cyclin 01. As expected, I saw 
decreased protein levels of Cyclin D 1 and a decreased association of Cyclin D I with its 
binding partner CDK-4. These events have been shown to be associated with a G 1/S 
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arrest (Diehl et al., 1998), indicating that TGF-~ stimulation of epithelial cells causes a 
decrease in cell cycle proteins. This also suggests this may be one of the mechanisms by 
which TGF-~ can halt the cell cycle in epithelial cells, independent of mad signalling. A 
possible model is that TGF-~ causes deactivation of Akt, making epithelial cells 
quiescent, and that Smad signalling is necessary for sustained maintenance of the cell 
cycle arrest program through increased transcription of p27 and other cell cycle inhibitory 
factors such as p21 (Laiho eta!., 1990). 
Thus far, the data described indicates that TGF-~ signalling through Akt is one 
pathway that differentiates fibroblast cells from epithelial cells. This novel pathway may 
help define how TGF-~ can cause one cell type to grow and another to halt growth. As 
well, in certain epithelial-derived cancer cells resistance to the anti-growth effects of 
TGF-~ has been shown (Reviewed in Ma sague, 2000; Elliot and Blobe, 2005) and in 
some cases these cells even respond by increasing growth. This pathway may also be key 
to EMT, a biological process where an epithelial cell acquires characteristics similar to 
fibroblasts. EMT is thought to be a defining event in the development of epithelial cancer 
metastasis, and TGF-~ may mediate this event even in normal epithelial cells (Elliot and 
Blobe, 2005). However, normal cells revert to normal morphology with withdrawal of 
TGF-~ while in carcinoma cells remain transfmmed. The activation of Akt under 
inappropriate circumstances may explain why such events happen, whereby the epithelial 
cells begin to take on a fibroblast-like phenotype. Overactive Akt may lead to the cells 
becoming resistant to TGF-~ growth inhibitory signals, causing the cells to behave like a 
mesenchymal cell type. 
68 
- -· ----------------- -------
Our data in epithelial cells conflicts with previous reports that either 1) show an 
increase in Akt activation in response to TGF-~ 1 stimulation (Yan eta/. , 2000; Shin et 
a!. , 2001; Jun et al., 2005) or 2) no change in Akt activation (Seaone et al. , 2004; Wilkes 
et al. , 2005). However, with respect to the 'Akt activation', the cell lines used were 
mostly cancerous lines, unlike the normal lines used here. Overexpression of normal Akt 
is observed at high frequency in the epithelial cancers such as pancreatic, ovarian and 
breast cancer (Bellacosta eta!. , 1995) and targeting Akt to the membrane can induce 
carcinogenesis in normal cells (Aoki et al., 1998). Therefore, the cell lines used may 
already have higher levels of Akt, and be umesponsive to TGF-~ inhibition. In addition, 
Akt was usually overexpressed, unlike our study, which used the endogenous protein. 
Overexpression of Akt may mimic a fibroblast or cancer like state in epithelial cells, 
where they do not respond normally to TGF-~ stimulation. Wilkes eta!. , (2005) describe 
no changes in Akt activation following TGF-~1 stimulation, however the cells in 
question were starved in low serum conditions and plated at a much higher density than 
this study. At the beginning of the thesis work, I undertook studies to determine the effect 
of cell density, and found more consistent results from plating a lower cell density (- 50% 
confluence versus 90-100% confluence). Cell density is an important determinant in cell 
growth, given that the cell lines used here display contact inhibition. Therefore, plating at 
higher densities may halt cell cycle progression and growth at the time of the assay. With 
regards to the low serum condition, if you were unable to detect a basal level of Akt 
phosphorylation (i.e. the cells have become quiescent), it would be difficult to determine 
the effect TGF-~ may be having on this signalling system. As well, epithelial cells 
respond to TGF-~ by going into G liS arrest. If the cells are quiescent (by both contact 
69 
inhibition and serum depravation), short-term responses to TGF-~ may be significantly 
reduced. Also, contact with other cells may increase responses to intergin/ILK- linked 
signalling either TGF-~ related or not (Wu and Dedhar, 200 I). Given that ILK is a 
potential Serine 4 73 kinase for Akt (Delcommenne el al. , 1998), an interesting avenue of 
research could be the relationship between cell density and activation of Akt through an 
intergin and TGF-~ linked mechanism. 
Chapter 4.4 Drosophila Model of TGF -fl/ Akt signaling 
One of the major questions left to be answered is whether this is a pathway for 
growth in vivo. To address these questions, I used the model system Drosophila to 
attempt to determine a genetic interaction between the TGF-~ type I homologue 
(Baboon) and PI3K signalling components. Babo mutants display a striking phenotype, in 
that they do not affect patterning, but instead influence cell proliferation in the 
developing larvae (Brummel et al. , 1999). Babo mutants have smaller brains and 
correspondingly smaller imaginal discs, with no signs of apoptosis but reduced cell 
proliferation. Since babo mutants die before adulthood, clonal analysis of the adult wing 
was undertaken, which results in smaller wings. An activated form of babo (Babo00) was 
expressed in the developing wing disc, which resulted in a 30% increase in organ size. 
Few other molecules in Drosophila have the ability to decrease imaginal disc size without 
patterning defects, with PI3K/Akt being another example (Leevers eta!., 1996; Verdu et 
a!. , 1999). 
Given the above phenotypes of smaller eye imaginal discs in babo mutants, I 
choose the developing eye as a system to study potential Baboon/PJ3K interactions. The 
Drosophila eye is a highly organized and repetitive structure made of individual cells 
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called ommatidia. Ommatidia! clusters are generated by a recruitment of cells behind the 
morphogenetic furrow and undergo dramatic growth and differentiation during larval and 
pupal stages to generate the adult eye (Baker, 2000). The eye also is an excellent system 
to study cellular growth decisions. When I expressed the normal Baboon receptor in the 
developing eye using both early and late drivers (eyeless-Ga/4 and GMR-Ga/4), it had 
little effect. This result is consistent with Brummel eta/. (1999) who saw little effect of 
overexpression of the normal receptor. I also misexpressed a DN-dActivin receptor, as 
dActivin is an endogenous ligand ofBabo, and saw no effect on cellular growth. 
Although this may appear surprising, however another TGF-~ ligand for Babo has since 
been found, dawdle (Parker et a!. , 2006). Dawdle therefore may signal upstream of babo 
to mediate some of its effects. 
To create an activated system, I used the previously characterized Babo00 
receptor. Using two different drivers (eyeless-Ga/4 and GMR-Ga/4), I found that Babo00 
caused overgrowth of the eye. Co-expression of a PI3K0 N with the Babo00 receptor 
caused a rescue of this phenotype, and overexpression of normal PI3 Kl Akt caused a 
synergic increase in growth. As well as an overgrowth phenotype, I found an increase in 
the size of the bristles in the eye. Coexpression with either dAkt or PI3K was additive 
with this phenotype. This suggests that Baboon° 0 can signal to dAkt or dPI3K and by 
blocking signals through dPI3K, a loss of signalling results. Therefore, Akt and PI3K act 
in vivo in the developing eye in a downstream pathway to a TGF-~ receptor, Baboon. 
I also characterized the Drosophila dFOXO and GSK-3~ homologues with respect 
to Baboon signalling. Coexpression of either mFOXO or dFOXO with Baboon° 0 resulted 
in a rescue, while coexpression with mFOXOAA resulted in little rescue of the FOXO 
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phenotype. This result indicates Babo rescues dFOXO through an Akt dependent 
mechanism. It also places Babo genetically upstream of dFOXO. These results agree with 
those of Kramer et al. (2003), where expression ofPI3K and Akt were also unable to 
rescue mFOXOAA phenotype. This again, strongly implies that dFOXO is a target of 
Babo activity in the developing eye. 
There is also strong genetic evidence from C. elegans for a TGF-~/FOXO 
pathway. DAF-7 (TGF-~ like ligand) is involved in dauer formation in C. elegans 
(Riddle and Albert, 1997). Dauer is a specialized state that L I larvae can enter upon food 
withdrawal or environmental stresses to help the worm survive. Another dauer pathway 
in C. elegans is the daf-2 /daf-16 pathway that is also implicated in longevity regulation. 
Daf-2 encodes insulin-like peptide and Daf-16 is the worm FOXO homologue. Both 
pathways are thought to mediate dauer arrest as separate arms. However, Runkvun' s 
group in 2001 demonstrated that DAF-7 could mediate DAF-16 nuclear relocalization at 
the L2 larval transition stage (Lee et al. , 2001). This was thought to be an indirect 
interaction. However, a recent report, implicates DAF-7 and insulin-like pathways more 
directly (Shaw et al., 2007). A microarray analysis of DAF-7 and insulin pathway 
transcriptional outputs indicated a high level of similarity between the two profiles. 
Analysis of DOD (Downstream of DAF-16) sites revealed a high level of DAF-16 
regulated genes downstream of DAF-7 signalling. DAF-16 was also required for DAF-7-
mediated increases in longevity, indicating it is genetically downstream of DAF-7. 
Finally, DAF-7 regulates DAF-16 nuclear relocalization and increases SOD-3,a target of 
DAF -16 transcription. The authors of this paper again suggest that the effects are indirect, 
however coupled with the evidence presented here, it seems likely that at least some 
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TGF-~-mediated responses signal directly to FOXO in a whole animal. dFOXO display 
a 'wandering larvae' phenotype and an inability to sense food that is thought to be 
analogous to the dauer state of C. elegans (Kramer et a!., 2003). FUJther research could 
be directed into dissecting if the role of DAF-7 on DAF-16 is through kt-dependent 
phosphorylation. Babo mutants could also be examined for sensitivity to nutritional 
challenges, and if this influences signaling to dFOXO. 
In addition to dFOXO, we also wished to see if the GSK homologue, Shaggy 
could ameliorate the Babo phenotype. Overexpression of Shaggy with Babo00 gave a 
partial rescue of the overgrowth phenotype. A form of Sgg that cannot be phosphorylated 
by Akt, Sggs9A provided more of a rescue than overexpression of the normal gg. Of 
special interest is the Shaggyoead construct, which showed an additive phenotype with 
respect to bristles, but not with the growth phenotypes. This suggests the kinase activity 
of Shaggy is needed for normal bristle outgrowth, but not suppression ofTGF-~­
mediated growth. 
Overall , the Drosophila results provide evidence that TGF-~ and PI3K/Akt signal 
together in vivo in the control of cellular growth. TGF-~ is normally cytostatic to 
neuronal cell lineages, however the role of Babo seems to be to promote cell proliferation 
in neuronal lineages. Activins however promote neurogenesis, and as Babo is closely 
related to both ligand families, it would app ar that this Type I receptor cau s a similar 
phenotype. However, as TGF-~ are also involved in late organogenesis, similar to Babo, 
it would be interesting to dissect out the role ofTGF-~ signaling to Akt in both 
developmental and differentiated contexts. 
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4.5 Conclusions and future directions 
Since TGF-~ causes fibroblasts to grow, increased phosphorylation of Akt and 
GSK-3~ represents another mechanism of growth control in conjunction to the previously 
characterized mad pathway. To our knowledge, this is one of the first reports of TGF-~ 
directly regulating cell cycle components, independent of RNA synth is. As well, the 
Drosophila TGF-~ Type I receptor, Baboon, interacts with PI3K/Akt signalling. A lesser 
interaction is seen with overexpression of GSK, suggesting that there may be other 
targets ofPI3K/Akt involved in TGF-~ mediated growth control in vivo such as FOXO. 
FOXO has also been implicated as a transcriptional binding partner for mads (S aone et 
al. , 2004), allowing for integration of multiple TGF-~ pathways. The activation of Akt in 
fibroblast, and the inhibition in epithelia by TGF-~ provide a mechanism for cell type 
specific response to growth. These results also provide a possible alternative mechanism 
for loss of growth control by TGF-~ in cancer, with epithelial cells potentially activating 
Akt and causing a lack of growth inhibition. 
However, this work raises several interesting questions. One is how the signal 
gets from the TGF-~ receptors to PI3K. Several possibilities could exist, the simplest 
being that PI3K binds directly to the TGF-~ receptor. Experimentally, one could use 
wildtype and mutant Type I receptor (L45 loop defective) to see ifPI3K can bind and 
transduce the signal. Previous research using an L45 loop defective mutant of Alk-5 was 
able to retain JNK activity, while losing Smad activity (Itoh eta!., 2003). If PI3K binds 
mutant Type I, then this would possibly indicate the signalling in fibroblasts is truly 
Smad-independent. The converse experiment could b carried out in epithelial cells, with 
wildtype Type I receptor in an attempt to see if they do bind at all. 
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As previously discussed in the introduction, this is unlikely it has already been 
suggested that an adaptor protein is probably needed (Yi et al. , 2005). However, a serious 
conceptual issue is that TGF-~ receptors do not have any phosphorylated tyrosines for a 
PTB adaptor protein to bind to. A tantalizing report by Galliher and Schiemann, 2007 
demonstrates that the tyrosine kinase Src can phosphorylate TGF-~ Type II receptors on 
Y284. They also demonstrate that this residue is essential for Grb2 binding, a PTB 
adaptor protein. TGF-~ Type II receptors lacking this site were unable to activate p38 
Mapk and bind Grb2. However, other groups have already suggested that the Type I 
receptor kinase activity is required for PI3K kinase activity (Yi e/ al. , 2005, Wilkes et al. , 
2006) and indeed the result generated in this study also suggest that both Type II and 
Type I kinase activity is needed for Akt activation. However, the TGF-~ Type I Receptor 
has recently been shown to be a dual specificity kinase, with the ability to directly 
phosphorylate SheA on both tyrosine and serine residues (Lee et al., 2007). This tyrosine 
kinase activity could help explain recruit ofPI3K to the TGF-~ receptors by adaptor 
proteins such as SheA. The authors also demonstrate that both receptors are needed for 
SheA phosphorylation, which leads to Grb2/Sos recruitment and downstream Erk 
activation. However, a major issue is how SheA is recruited to the Type I receptor when 
there is no apparent phosphorylated tyrosines, and the PTB domain of SheA was thought 
to be essential for the interaction. The tyrosine 424 of the Type II receptor is highly 
conserved with Type I receptor and forms a potential PTB binding motif. Performing site 
directed mutagenesis on these sites in both the Type I and II receptors, and seeing ifthis 
1) eliminates She recruitment and phosphorylation and 2) eliminates PI3K activation and 
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Akt phosphorylation in fibroblasts would allow one to see if recruitment of adaptor 
proteins is truly essential in activation of PI3K. 
An additional potential 'adaptor' for the TGF-~ receptors is ErbB3, a EGF 
receptor that can bind ligand, but is unable to convey the signal into the cell dir ctly as it 
lacks a kinase domain. Another recent report demonstrates that TGF-~ can increase 
association of ErbB3 with the p85 subunit of PI3K, which is assumed to be caused 
indirectly by TGF-~ inducing phosphorylation of another regulatory protein, TACE 
(Wang eta!., 2008). This occurred in cancerous epithelial cells, so it would be interesting 
to see if a similar trend happens in 'normal' cell lines, and ifnot, this could b a key 
regulatory component to the loss of cytostatic growth control in cancerous pi thelia) 
cells. 
Another possibility is that there are other signalling components acting between 
PI3K and Akt. In our lab we have shown that the ILK kinase activity on Akt is 
upregulated in response to TGF-~ stimulation in fibroblasts. The activation of the ILK 
kinase could explain many of the cell density effects seen in this work, such that tightly 
packed cells have increased Akt signalling through the activation of intergrins. To test the 
dependence of ILK in TGF-WAkt signalling one could employ gene knockdown 
techniques such as RNAi or morpholinos to attempt to assess ILK function . Another 
approach would be to further clarify the targ t the Akt IV inhibitor acts upon, as it does 
act on the upstream Serine 473 kinase. 
Other potential input into these signalling pathways is PTEN. I have done 
preliminary blots that show an increase in phosphorylation of PTEN in fibroblasts and a 
decrease of phosphorylation in epithelial cells. Phosphorylation of PTEN inacti ates the 
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protein ' s activity (Torres and Pulido, 2001) , which would result in less phosphatase 
activity at the inositol phospholipids produced by PI3K. Increasing PTEN 
phosphorylation would result in more phosphatase activity in epithelial cells, indirectly 
leading to decreased Akt phosphorylation. This would also h lp explain how Akt is 
actively dephosphorylated by TGF-~ stimulation in epithelial cells. 
One potential issue with this theory is how the signal gets transduced from the 
TGF-~ receptors to PTEN. PP2A is a potential cofactor of the TGF-~ receptors 
(Petritsich et al. , 2000), and can mediate G 1 arrest in epithelial cells. PP2A can also 
dephosphorylate PTEN, providing a potential method of regulation in epithelial cells. 
One potential way of addressing this question would be the use of PP2A inhibitors to see 
if this could block TGF-~ effects on PTEN and Akt phosphorylation. PTEN 
phosphorylation may be potentially regulated by PP2A, providing a possible link between 
the TGF-~ receptor and down regulation of Akt signaling in epithelial cells. 
Other possibilities for epithelial cells are that the trends noted in this thesis are not 
truly Smad-independent. A direct way to test this would be to use the L45 loop mutant 
ALK-5 to see if the Akt dephosphorylation is seen in the absence of Smads. Also, there 
are several Smad knockout mice that could be combined to generate a Smad 2/3 null line 
that would avoid the artifacts of overexpression that might be seen with using the 
receptor lines. Use of inhibitors oftranslation and transcription could also add in 
dissecting out if the epithelia phenomena are truly independent of Smad transcription. 
If the data in epithelial cells is Smad-dependent, one potential method of 
regulation could be through the lipid phosphatase SHIP (Itoh et al., 2007). Smads have 
previously been implicated in influencing SHIP levels. Since SHIP takes the P3 
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phosphate off the PI3 lipids, this may lead to inhibition of Akt phosphorylation. This may 
also explain the 'delay' in signalling seen in epithelial cells versus fibroblasts ( 120 
minutes versus 90 minutes), as the events may rely on transcription. 
Downstream of Akt, the FOXO transcription factors have not been fully studied 
in fibroblasts versus epithelial cells. There is already evidence (Seaone et. a!, 2004) that 
FOXO is involved in TGF-~ mediated arrest of the cell cycle via interactions with 
Smads. Since Akt is clearly differentially regulated in fibroblasts versus epithelial cells, 
this could provide an additional target of Akt to help explain growth regulation. Also, the 
results from the Drosophila work hint that dFOXO is a more critical target of dAkt 
activity than GSK, with respect to the growth of the developing eye. 
Finally, it remains to be seen ifTGF-~-mediated signalling through Akt is 
perturbed in epithelial derived cancers, such as breast cancer. Repeating some of the 
experiments outlined in this thesis in breast cancer cell lines of varying metastastic ability 
and correlating it to Akt activation could shed light upon this question. 
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